Cheap Protection From FLU Season 2009

File this one away for September 2009 when we are headed into flu season.  Mark this is important and a must have item by that time and continue to use it through Nov, Dec.  Why? because it increases immune factors in your body by 1700%!   We will all want our families to be well protected from the coming flu season – this is the best protection I have seen to date.

Cheap product to protect you from the flu ->

Enhanced Super Digestive Enzymes with Probiotics, 100 vegetarian capsules

less than 25.00

From Drug Discovery and Development:

New Study Suggests That GanedenBC30 Increases Immune Response to Cold and Flu
Drug Discovery & Development – May 13, 2009

A promising new study in the March issue of Postgraduate Medicine suggests that a strain of probiotic bacteria, GanedenBC30 (Bacillus coagulans GBI-30, PTA-6086), increases the body’s immune response to viruses that cause common viral respiratory tract infections such as colds and flu. Study data showed significant increases in T-cell production of TNF-alpha, a key immune marker, versus control upon exposure to adenovirus and influenza A in healthy adults who consumed a daily capsule of GanedenBC30 for 30 days. While many health professionals believe that probiotics can help people who have specific health conditions, there has been controversy surrounding the benefits of probiotics in healthy people. The new study supports the idea that probiotics can indeed benefit those who are healthy.
The study measured the changes in blood TNF-alpha levels upon exposure to adenovirus and influenza A in 10 healthy adults prior to and following a 30 day regimen of GanedenBC30, which is marketed as a dietary supplement called Sustenex and is also available in a variety of fortified packaged foods. Results showed a 250% increase in TNF-alpha levels with adenovirus and a 1709% increase in TNF-alpha levels with influenza A after subjects took the probiotics for a period of 30 days. Increased production of TNF-alpha in response to viral exposure indicates a heightened immunological effect.

Colds and flu are the most common illnesses among humans. They have significant health and economic consequences, especially among young children, the elderly, and people with underlying or chronic conditions. Every year, an average of 5 to 20 percent of people in the U.S. contract the flu, more than 200,000 people are hospitalized with flu-related complications, and approximately 36,000 people die from the flu. It is also estimated that 1 billion colds occur annually in the US.

“These results demonstrate the ability of GanedenBC30 to boost the immune system of healthy adults against viruses that cause some of the most common human illnesses,” said Mira Baron, MD, author of the study. “The study helps support the long-suspected belief about the beneficial effects of GanedenBC30 on the immune system and adds to the emerging body of evidence that probiotics can benefit healthy people as well as those with specific health issues.

Probiotics are live, beneficial microorganisms similar to the “friendly” bacteria found naturally in the body’s digestive system and have best been known for their ability to support the body’s digestive system by helping to reduce symptoms of digestive disorders such as irritable bowel syndrome (IBS), diarrhea, gas, and bloating. Researchers have long postulated the role probiotics play in boosting immune function through promoting a healthy bacterial ecosystem in the digestive tract, which comprises approximately 70 percent of the body’s immune system, a hypothesis supported by the current study.

“The results of this research are interesting and set the stage for the continued study of the effects of the GanedenBC30 strain of probiotics on the immune system,” said Dr. Justin Sonnenburg, an assistant professor of microbiology and immunology at the Stanford University School of Medicine, who has reviewed the study’s findings. “The standard practice today is for people to take medicine to achieve symptomatic relief of colds and flu, but this research hints that healthy adults may be able to boost their immune system to potentially ward off infection and prevent such illnesses.”

The study points out that different strains of probiotics have different inherent properties, suggesting that the unique ability of GanedenBC30 to survive common conditions that can potentially kill other probiotics before they can have a beneficial effect, such as manufacturing conditions, extreme temperatures, and the harsh gastric environment, may contribute to its ability to support the immune system. Dr. Ken Alibek, MD, PhD, ScD, an infectious disease, microbiology, and immunology expert who has studied Bacillus coagulans extensively, believes that the strain may be the most ideal in existence, noting that “no other probiotic has the ability like that of Bacillus coagulans to survive the challenges probiotics face in reaching the intestinal tract where they can do good” and added that “once there, no other strain is as prolific in producing the beneficial by-products responsible for many of the benefits of probiotics.”

“This study is another step forward in our understanding of probiotics and the many health benefits they can deliver,” said Andrew Lefkowitz, CEO of Ganeden Biotech, which helped fund the study through a research grant and has completed a total of seven clinical trials using GanedenBC30, including trials in immunity, IBS, intestinal gas, Crohn’s disease, osteoarthritis, and rheumatoid arthritis. “We will continue to fund research investigating the benefits of GanedenBC30 and its ability to improve the quality of life.”

Enhanced Super Digestive Enzymes with Probiotics, 100 vegetarian capsules Enhanced Super Digestive Enzymes with Probiotics, 100 vegetarian capsules

Enhanced Super Digestive Enzymes with Probiotics 100 vegetarian capsules Item Catalog Number: 01273 The aging process and certain health issues cause a reduction in the body’s enzyme production. One effect of this reduction is a bloated feeling soon after eating a


Date: March 12, 2009
Source: Ganeden Labs

Tags: , , ,

John needs our help – Gulf War Vet

Tags: ,

Swine Flu – What You’ve Not Been Told

My desire over the last year has been to create awareness of the competing agendas of medicine and the pharmaceutical industry.  Unfortunately we the American people have been convinced over the years that our health is centered around symptom control instead of curative healing systemically.   In his article regarding the swine flu Mike Adams, the health ranger, provides us with a view into the pharmaceutical industry that is so clear we may have overlooked the knowledge we can gain by reviewing it more carefully.

So Roche owns Tamiflu the great savior of us all when it comes to swine flu, Mike points out that Tamiflu is at its core nothing but a Chinese cooking herb modified by Roche so that it can patent its properties.  Mike further describes many alternatives to Tamiflu that are all around us and can act in a manner similar to Tamiflu without any issues with distribution.

One 75mg dose of Tamiflu is at its core 1/10 of 1.3 grams of star anise a chinese spice used in cooking.

It took me 30 seconds to find 22 grams of Star Anise for $3.95 that is enough raw material to make more than 160 doses.

Tamiflu on the other hand is available on the Internet at 10 capsules for 44.00 I guess it costs a lot to grind the Star Anise and put it into the little 75mg gel caps.

Today from Food Matters by way of Natural News -

By Mike Adams

If you read the stories on H1N1 influenza written by the mainstream media, you might incorrectly think there’s only one anti-viral drug in the world. It’s name is Tamiflu and it’s in short supply.

That’s astonishing to hear because the world is full of anti-viral medicine found in tens of thousands of different plants. Culinary herbs like thyme, sage and rosemary are anti-viral. Berries and sprouts are anti-viral. Garlic, ginger and onions are anti-viral. You can’t walk through a grocery store without walking past a hundred or more anti-viral medicines made by Mother Nature.

And yet how many does the mainstream media mention? Zero.

The totality of influenza preparedness is defined by the mainstream media as the number of doses of Tamiflu a nation has stockpiled. To live in a world that’s saturated with natural anti-viral medicine and then not even acknowledge it in the media is beyond bizarre. It’s Twilight Zone-like. It’s like we’ve been teleported to an alternate universe where anti-viral plants have disappeared… or at least everyone is pretending they have.

Where do you think Tamiflu comes from, by the way?

It’s extracted from the Traditional Chinese Medicine herb called Star Anise. It’s one of hundreds of different anti-viral herbs found in Chinese Medicine, not to even mention anti-viral herbs from South America, North America, Australia, Africa and other regions.

I find it downright comedic that Big Pharma and the world’s health authorities extract their “champion” anti-viral drug Tamiflu from a Chinese Medicine herb, and then they go out of their way to announce to people that herbs and natural remedies are useless against influenza. If that’s the case then why are they using herbs to make their own medicine?

How many stories have you read that bother to tell you Tamiflu is made from the star anise herb that’s been used for over 5,000 years in Traditional Chinese Medicine? Virtually none. The powers that be don’t want anybody to know they could actually grow their own medicine in a garden or a windowsill. If you can grow cilantro, you can grow medicine. If everybody figured that out, Big Pharma wouldn’t be reaping the enormous profits it’s making right now from Tamiflu sales, and the governments of the world wouldn’t be able to scare and control people by promising to distribute Tamiflu (but only if you behave).

H1N1 influenza is not a hoax. But the way it’s being reported by health authorities and the mainstream media certainly is. The scam in all this is what they leave out of the stories — the fact that human beings live among a huge natural medicine chest of anti-viral drugs found in every city park, every forest, every swamp and every open field.

You cannot walk across any patch of natural land in America and NOT find anti-viral medicine. It’s everywhere! It’s in the weeds growing in the cracks in the sidewalks; it’s in weeds on the side of the stream; and it’s growing in the small patch of dirt left remaining in the median between highway lanes. In the deserts of the American Southwest, you can’t even drive to work without passing mile after mile of abundant anti-viral medicine grown by Mother Nature and just waiting for humans to wake up and be smart enough to recognize it.


I found this on the web after reading the article regarding Star Anise -

According to Roche, the major bottleneck in oseltamivir production is the availability of shikimic acid, which cannot be synthesised economically and is only effectively isolated from Chinese star anise, an ancient cooking spice; the herb is also used in Traditional Chinese Medicine. Although mostautotrophic organisms produce shikimic acid, the isolation yield is low. A shortage of star anise is one of the key reasons why there is a worldwide shortage of Tamiflu (as of 2005). Star anise is grown in four provinces in China and harvested between March and May. It is also produced in Lang Son province, Vietnam. The shikimic acid is extracted from the seeds in a ten-stage process. Thirteen grams of star anise make 1.3 grams of shikimic acid, which can be made into 10 oseltamivir 75 mg capsules. Ninety percent of the harvest is already used by Roche in making oseltamivir.

Tags: , ,

Cancer Clinical Trials May Be Biased

The simple truth is that our system is for sale.  There you have it, researchers are capitalists too.  Yes this is first hand knowledge, research is done because someone with an agenda is willing to pay to have a point of view propagated – further they are willing to do so at any level and at almost any cost.  It is absolutely no surprise to me that cancer research has gone no where in the last thirty years.  Think about it what happens to the American Cancer Society if cancer gets cured, what does your friendly radiologist do for a living if a new cancer vaccine is discovered that can cure most cancers with a couple of shots.   Why is it that apricot seeds are not sold in stores like sunflower seeds? 

Some answers are hard to swallow this article for me is not supprising just simply disappointing.

A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that conflicts of interest may cause some researchers to report biased results that are favorable to companies. Ties between clinical researchers and companies that make medical devices and drugs have become increasingly complex and controversial, particularly as more researchers compete for scarce federal research funds. In addition to using industry money to support their research, some investigators receive consulting fees, own stock and hold positions within companies that profit from selling the very products they are investigating. These conflicts of interest have raised concerns that studies with ties to industry are biased and are not designed to provide a true test of medical therapies. Many medical journals now require researchers to disclose potential conflicts of interest in the articles they submit for publication.

To get sense of the frequency and impact of conflicts of interest in clinical cancer research, Dr. Reshma Jagsi of the University of Michigan and colleagues reviewed cancer studies appearing in eight highly regarded journals in 2006. These journals included the New England Journal of Medicine; JAMA; the Lancet; the Journal of Clinical Oncology; the Journal of the National Cancer Institute; Lancet Oncology; Clinical Cancer Research; and CANCER.

Of the 1,534 cancer studies identified in these journals, 29 percent had conflicts of interest that were apparent from review of published author declarations and authorship lists (including industry funding, consulting fees to authors, co-authorship by industry employees, etc.), and 17 percent declared industry funding. Conflicts of interest were most often found in articles with primary authors from departments in medical oncology (45 percent), those from North America (33 percent), and those with male first and senior authors (37 percent).

According to the authors, randomized clinical trials that assessed patient survival were more likely to report a survival advantage associated with the intervention when a conflict of interest was present. These trials are the foundation by which drugs, technologies, diagnostic tests, etc. get approved for use in the clinic and therefore shape the way oncologists practice medicine.

The findings also show that studies with industry funding were more likely to focus on treatment than studies without industry funding (62 percent vs. 36 percent). They were less likely than studies not declaring industry funding to focus on epidemiology, prevention, risk factors, screening or diagnostic methods (20 percent vs. 47 percent).

This analysis revealed that conflicts of interest exist in a considerable number of clinical cancer research articles published in important journals. The authors noted that “attempts to disentangle the cancer research effort from industry merit further attention, and journals should embrace both rigorous standards of disclosure and heightened scrutiny when conflicts exist.”

Tags: ,

Diet and Cancer – Critical Choices

Originally published in icon Issue 1 2007

Diet1To change, or not to change, that is the question.

When it comes to cancer, many people diagnosed with the disease make significant changes to their diet, in order to give themselves the best possible chance of survival. However, at the end of November 2006, the British Medical Journal carried a ‘personal view’ from Professor Waxman of Imperial College, London, in which he states that ‘we know that once cancer has been diagnosed, no change in diet will lead to any improvement in cancer outcomes. In a recent review of 59 randomised trials of dietary manoeuvres in cancer no evidence was found that supported this approach’.

Surely this cannot be true? Professor Jane Plant, of the same Imperial College, London thinks this is complete rubbish; that diet clearly can help survival. And she should know having beaten her own cancer that way, when orthodox medicine had failed her.

For my own part I wondered about all the research we had covered in Cancer Watch. For example:
- That lycopene helps reduce prostate cancer symptoms by up to 40 per cent (Harvard)
- That vitamin D can have a significant benefit when incorporated in treatment programmes (Harvard, various)
- That Ellagic Acid (eating raspberries!) can help with Cervical lesions (Johns Hopkins)
- That 4-10 cups of green tea per day ‘can stop leukaemia ion its tracks’ (The Mayo Clinic – although I’m really not sure I believe that one!)
- That vitamin K stopped liver cancer progression in 6 of the 30 cases in clinical trials (Washington Uni/Tokyo)
- That beneficial bacteria in clinical trials had a significant benefit for colon cancer patients – as did fish oils and vitamin D. (Various)
We have reports that natural vitamin E aids the action of tamoxifen, that indole 3 carbinol aids breast cancer drugs, that vitamin D improves the success of radiotherapy, that Red Clover improves survival rates in breast cancer patients. Can they all be wrong?

So to help all readers of our web site to get started in this area, we have prepared this thorough review of what ‘diets’ you may or may not contemplate using alongside your orthodox medicine. A separate review of specific Diet Therapies, which can be used as ‘Alternative’ treatments (e.g.Gerson, Plaskett, Gonzalez, Hoxsey and Pfeiffer etc) can be found under the section marked Diet Therapies.

I Changing Diets to Help Beat Cancer.

There can be absolutely no debate that poor diet is a contributory factor in the cancer forming process.  The World Health Organisation believes at least 35 per cent of cancers have poor diet as their root cause.

We find this rather misleading.  Cancer development is a complex issue and involves a multi-step process.  Many factors may combine and in a way that is as individual as you are. Everyday each of us makes cancer and pre-cancer ‘rogue’ cells as by-products of our metabolism. These are normally ‘killed off’ by a healthy immune system. We believe it is easier to understand that, whilst a few factors (like radiation) may cause direct damage to your DNA, many factors (like poor diet, toxins, infection) may weaken your immune system.  If the immune system cannot cope with rogue DNA messages, cancer cells are freer to start their ‘colonisation’ of your body.  Even then they must multiply, taken on blood supplies, fire off around the body, etc. So you can see that diet may play a part, but rarely is it the only contributing factor to the development of a cancer.

Preventing cancer. Or preventing cancer recurrence

At our 2004 Cancer Prevention Conference, the audience was a little surprised when one speaker, our own patron Professor Tony Howell stood up and talked not about preventing the first cancer in the body but about  preventing the cancer taking a further hold once a patient had been diagnosed, treated and given an all clear. In other words, preventing recurrence. Of course, he was absolutely right to do so as that is where the majority of the Breast Cancer budget is successfully directed. But why should the same logic not apply here? You’ve been diagnosed, even treated and are ‘in  remission’. Given we know that diet plays a vital role in cancer prevention, why wouldn’t it play a vital role in preventing the cancer coming back?

For most cancer patients this is exactly the issue: ‘I don’t want my cancer coming back. I’m going to do everything in my power to prevent it’.

Poor Diet as a contributor to cancer

The stark fact is that nothing beats a good, nutritious diet, involving whole grains, fruits and vegetables and fresh fish.  But how does an individual know if they are getting a good diet?  There is so much conflicting advice.

Take the Government’s recommendation of five lots of fruit and vegetables per day.  In France this is ten and, in America since 2006, it is 13.

Then we have had ‘healthy eating pyramids’ and all too numerous food fads.  The current Food Standards Authority recommendation is equally unhelpful in that it suggests you should ‘eat a little of everything’.  Personally, I don’t want to eat a single molecule of trans or saturated fats, dairy, or refined carbohydrates, let alone excess salt or glucose – as is commonplace in our supermarkets.

One self-evident problem is rising levels of obesity. US research shows that people more than 7 kgs overweight are statistically more at risk of cancer than if they smoke. Part of this is a link to our rising insulin levels, manifested in rising late-onset diabetes, and increasingly thought to be a driving force in cancer. Indeed ‘insulin control’ and cancer is a new ‘hot-topic’ in the USA. Here is the first clue that the research Waxman quotes may be misleading. A study at the end of 2006 from the University of North Carolina has provided evidence about a link between breast cancer survival times and a woman’s excess girth.  In this particular 9-year study the overweight women had an increased risk of death of 48 per cent overall, which increased the more they were overweight. However if they lost weight, they increased their chances of survival. Isn’t correct diet the main way of losing weight?

Deficiencies and cancer risk

It is becoming increasingly clear that deficiencies in certain vitamins, minerals and even hormones are linked to increased cancer risk.

For example, Harvard Medical School have done a lot of research on omega 3 (fish oils) and vitamin D.  Professor Hollick has stated that there would be ’25 per cent less fatalities from Breast Cancer if women took adequate daily levels of vitamin D’.

The Americans conducted the China study using various antioxidants and a total sample of over 200,000 people over five years to 1993 and showed figures of 13-17 per cent less cancers with groups taking three antioxidants; beta-carotene, vitamin E and selenium.

The French conducted the seven-year Su.Vi. Max study and concluded that the group taking a five-ingredient antioxidant supplement (beta-carotene, vitamin E, vitamin C, zinc and selenium) had 31 per cent fewer cancers during the period.

I could give more vitamin examples, but instead let us turn to minerals.  Deficiencies in potassium and magnesium, heightened by excesses of sodium, help to poison our cells, increasing their acidity and decreasing their oxygen levels.  This, in turn, weakens the energy production system and weakens the p53 gene, which defends the cells from becoming cancer cells.  US research in 2005 showed that 40 per cent of US citizens were magnesium deficient; you can bet that’s the case in the UK too.  Magnesium and potassium are plentiful in nuts, whole grains, greens, apricots, carrots, apples and all the foods young people do not eat any more.

A research study carried in Cancer Watch in 2005 showed the dreadful diet of our children – their top ten foods included no fruits, vegetables or fish but plentiful chips, crisps, pizza, chocolate, cakes and ice cream.  When they do eat grains and cereals, they are ‘refined’ and virtually vitamin free.

But how nourishing are today’s fruits and vegetables?  Two studies reported in 2005 (for example, Cornell University), both carried in Cancer Watch, recorded mineral declines in our fruit and vegetables over the last 40 years of up to 70 per cent depending upon the mineral and item concerned. This ‘soil deficiency’ (and it applies whether you are eating organic or non-organic unless the soils have been enriched) is clearly noted in the USA, where three Senate Hearings since 1934 have concluded that people should supplement because of increasing demineralisation of our soils through overproduction.

But worse, our food is increasingly picked unripe and sent from Thailand or Kenya.  A week later it moves from Covent Garden to your supermarket.  This process means that the items carry fewer vitamins to start with and the delay reduces levels further.  Fruits can lose nearly 50 per cent of their vitamin C after just 5 days storage.

The figures and the facts are there for all to read.

Dietary factors that heighten risk?

Worse still; are there foods that might actually do more harm than good?  Again there is hard evidence of increased risks with certain foods.

We’ve known about the dangers of saturated fats for years, but the worst are undoubtedly trans fats.  McDonalds has been fined over theirs; many firms have cut them out.  The US government requires on-pack labelling on all foods, warning on trans fat levels; the UK is not up to speed yet.

Then there are foods such as glucose, salt and dairy.

Glucose is the favourite food of the cancer cell and we have covered several studies in icon, notably from Harvard, which show that glucose encourages and feeds cancers – directly or indirectly through insulin levels.  This is aided by our move to one or two large meals per day rather than six small ones, especially as our meals are so full of refined carbohydrates.  Refined pasta has a very high glycaemic index – i.e. it’s rather like eating neat sugar.

Then there is salt.  The Food Standards Agency still recommends 6gm per day.  In my book The Tree of Life: The Anti-Cancer Diet, I recommend a maximum of 1gm.  The USA recommendation in 2005 was lowered to 1.25gms.  Sodium, in excess, poisons your cells and sets up pre-cancer conditions, reducing oxygen and increasing acidity.  Fact.

Finally, there’s Insulin-like Growth Factor 1, and you find that in cow’s milk.  IGF-1 is what makes baby calves grow to full size in ten months.  You do not want your cells dividing that fast and there is now plenty of research (For example, the Karolinska Institute in Sweden) linking this hormone to increased risk of cancer.

The ideal diet?

One diet well worth looking into is the Macrobiotic diet.  Unfortunately, it has been given a rather ‘cranky’ press because of its association with certain pop stars.  You will find the detail of the diet on by clicking here

Over 100 years ago, Sagen Ishizuka, a Japanese army doctor, lamented the increased westernisation of the traditional Japanese diet.  After eleven years of studies, he developed a diet based on five principles:

1. Food is the core of your health.
2. Sodium and potassium are opposites – the latter must balance the former.
3. Whole grains are the staple food of man.
4. Food should be unrefined, whole and natural.
5. Food should be freshly picked, locally grown and in season.

How ‘cranky’ is that?

Another we have covered in detail was prompted by in-depth US research – the Mediterranean Diet. This diet is based on whole grains, plenty of locally picked fresh fruit and vegetables, olive and nut oils, garlic, fresh oily fish and sunshine. Oh and apparently, according to the research, you can drink up to 4 glasses of red wine a day!

If you want longevity, the diet for you is the Okinawan Diet. They actually consume 40 per cent less calories than even the Japanese, and live on atolls surrounded by coral reefs – so their fresh fish, fresh fruit and vegetables and whole rice diet is full of minerals. They also consume virtually no sodium salt other than from the sea – a major factor in all the Epidemiology studies on groups of people (like the Bush people) who live longest in the world.

Calorie reduction is also a major factor. I mentioned the increased risks of cancer with being overweight or obesity above. A number of studies (for example, on populations during wartime, and on laboratory rats) on calorie reduction – where you consume 5-10 per cent less calories than you actually ‘need’ – show less illness and increased longevity.

Many people write to us and complain that we do not take anti-meat, pro Vegetarian Diet stance.  It is quite clear from research studies that increased levels of red meat consumption heighten cancer risk and increase factors such as blood cholesterol levels, so we do think people should moderate their red meat consumption……..but…….research findings that vegetarians have less cancer usually omit the fact that vegetarians smoke less and consume less alcohol.  They do not live longer as they still consume high salt levels like the non-vegans, and some even consume too much dairy.

Moreover our view, put simply, is that one man’s meat is another’s poison and we support the whole principle of professional metabolic typing. Many health writers point East and talk about low meat consumption and low cancer levels, neglecting to talk about lowered stress levels, lower dairy levels or considerably higher levels of everyday physical activity.  Moreover, there are at least four different biochemical types of person in the world.  The foods that one population group thrive on may well not do so well for a different biochemical population group.  We may well all be ‘humans’ but we have developed over the last 20,000 years in an equilibrium with our localised environment. Metabolic typing was also the basis for William Kelly’s successful work in the US in the 1970s, and that has led to Dr. Gonzalez and his diet therapy regime, currently performing with great success in clinical trials in New York.

Diet2

Why the debate? Does changing diet help or not?

The truth is that, whilst we can find specific research on specific natural compounds with specific cancers, there just do not seem to be any significant studies on cancer groups where groups making diet changes have been balanced by groups that have not.

The problem is that logically if a poor diet contributed significantly to a person’s cancer, you would expect that at least some of these patients might benefit equally from a good, corrective diet. At least that was the principle which originally drove the work of Dr Max Gerson. We will cover his work more fully in the next issue. However, maybe cancer cells are not logical.

Changing one’s diet is not simply for corrective nourishment reasons. It allows the patient to ‘take some control’ over their own cancer treatment. It nourishes the soul, and the mental state too. But this takes us well outside a Doctor’s training and understanding. There are no UK clinical trials on mental state.

Losing patient control is a real concern for your doctor but I have little sympathy for this. Patients want knowledgeable dialogue and discussion, not ‘control’ especially where their own lives are concerned. Too often they are ignored, ‘spoken down to’ and even belittled by oncologists.

So they go looking for alternatives. And we all know that there are professionals out there who really do know their subject; experts like Naturopaths and Nutritionists, who have studied at university for just as long as the oncologists, who spent just a few days learning about nutrition at best. And herein lies the biggest problem.  I won’t ask my plumber to do the conveyancing on my house, and I wouldn’t ask an oncologist to advise me on nutrition.  He is simply not adequately trained in the subject. But. The truth is that despite the expertise of Naturopaths and nutritionists, we do not have research numbers – only anecdote. And clinicians and oncologists, like Lina Evangelista, don’t get out of bed in the morning unless serious numbers are involved.

Is there any hard evidence?

In truth, the biggest problem is that the supporting ‘evidence’ is nearly all anecdotal – and that’s not good enough. But then who would organise the research, or pay for it? Cancer Research UK don’t seem interested, and we have no Government body as they do in America to check out these things. Recently, UK research to study the effects of six natural compounds each of which had already shown promise in treating brain tumours could barely raise any funding at all. If the $70 billion pharmaceutical business thinks clinical trials are prohibitively expensive, what chance the much, much smaller vitamin industry?

Many people choose to ‘turn vegan’ in their attempts to beat the disease. One such plan involves following the Bristol Cancer Centre (now renamed Penny Brohn Cancer Care) Diet.  So we contacted Chris Head, CEO of Penny Brohn Cancer Care, and he confirmed that they have no research that supports their diet, adding that this doesn’t mean the diet doesn’t help, just that we don’t have any research. In a further e mail to me he added that they have now decided to conduct research to cover this – we will keep you informed.

This diet is based around whole grains (but not wheat), lots of pulses, seeds, cold pressed oils and organic fruit and vegetables.  They suggest avoiding dairy, red meat, and saturated fat.  The full diet can be found here. Again, no one is suggesting using this instead of orthodox therapy. For my part I would emphasise that, if you do cut out meat, please add vitamin B-12 into your supplements list – a good source would be chlorella. There is a wealth of evidence that B-12 deficiency is linked with an increased cancer risk. And meat is the prime dietary source. You could even be exacerbating your problems.

a) Correcting the deficiencies

Surely it makes enormous sense to give yourself the best possible chance of beating your cancer? If you were overweight or consumed too much salt or too little potassium and magnesium before diagnosis at least correct and give yourself a fighting chance??  Isn’t it simply common sense for a cancer patient to want to eat as healthy a diet as possible, thus trying to overcome any shortfalls in vitamins, or minerals that they might have amassed? Isn’t it logical that they would now want to ‘take care of themselves’? Shouldn’t the cancer patient be encouraged in this – encouraged to eat the good things and cut out the bad?  Or are our medical professionals recommending you carry on with the hamburgers, pizza and chips?

Well actually, yes. The Royal Marsden Dieticians produce a booklet on a diet for chemotherapy which has little pictures of milkshakes, cheeseburgers and sugary buns in it – a complete failure to understand the biochemistry of cancer, and one highlighted only recently by research on glucose from Harvard which concluded that people with cancer should cut their glucose levels significantly. Frankly it beggars belief. At the very moment the doctors are trying to kill off a patient’s cancer cells, the dieticians are chucking animal fats, salt, glucose and refined rubbish down their throats. Now we do understand that they only see the seven per cent of patients with serious weight loss problems and this can prove fatal in itself, but publishing booklets for ALL chemotherapy patients suggesting this Dieticians’ Diet is lunacy. Dieticians would be well advised to examine in detail the Russian clinical trials on the use of Hydrazine Sulphate, as a way of breaking the weight loss cycle that can occur in cancer patients.

Personally, I favour the nuts, pulses and whole grain approach, as I’d like my cancer cells to starve rather than be fed!  Click here and here for our diet for chemotherapy .

New patients ringing our offices are almost always nutritionally deficient, and nutritionally toxic. Quite simply, many patients have eaten such a poor diet, high in refined sugary, salty foods, aided and abetted by stress, coffee, fizzy drinks and so on, that their bodies have deficiencies and their cells are acidic. As we said above, this pushes the cells to a state of lowered oxygen and lowered energy. The cells have excesses of certain factors, and deficiencies in others like potassium and magnesium. One simple approach to diet is to try to return the body to its correct pH, which is slightly alkaline. You will find the Alkaline Diet here on our web site and you will find the foods and factors that can return you to this more natural state, increasing cellular oxygen. Again, the approach is the basis for the Gerson Therapy, refined by Lawrence Plaskett, who is Vice Chair of the UK Nutritional Council, and part of the Gonzalez Therapy for which there are clinical trials.

b) Supplementation

Various hospitals in the USA use supplementation like vitamin D, or melatonin (Asphalia) to treat cancers.  Others use herbs like astragalus or red clover. Some use genistein or fish oils.

Now, we have consistently taken a strong line against US websites claiming that coral calcium, or essiac, or those high street bottles of shark cartilage ‘cure’ cancer.  They don’t. We could give many other examples, and we do on our web site, based on factual evidence and research.

But the fact is that there is also a lot of excellent research involving large numbers of people where, clearly, certain vitamins, minerals and hormones – when supplemented – do play a significant and beneficial role.  A visit to the Nutritionals section of our website will show the sheer depth of top quality research available.

The French Su.Vi. Max study previously mentioned also reported a 37 per cent decline in male deaths from cancer during the 7-year period, the US China Study showed a 21 per cent decline in mortality during the 5-year study.  Both studies indicate supplementation doesn’t just prevent cancer, it clearly can have an effect in increasing survival times.

But drugs companies know this.  In Cancer Watch (Issue 1, 2007) we cover a new drug and its clinical trials – What is it?  A concentrated form of vitamin D.
Then there’s the whole history of plants and herbs, again much studied by the pharmaceutical companies. Recently Alan Hopking, writing in icon, said, ‘Many plants have furnished modern medicine with drugs that are used in cancer therapy as cytotoxic agents: recently the product known as Taxol, from the Pacific Yew tree, for breast cancer, and the vinca alkaloids from the Madagascar periwinkle. These compounds are effective as anti-cancer agents by virtue of their nature as poisons, which disrupt the cell cycle. Their destructive nature as poisons is clear. However the fact that plants were the original source of some pharmaceuticals, the classic example being Withering’s use of the cardiac glycosides of the foxglove for dropsy, can blur the distinctions between two very different kinds of agents – medicines and poisons’. In other words, just because some herbs are lauded as the basis for chemotherapy drugs, please don’t think that is their only – or even major – benefit, as he went on to show. Herbs have helped in a curative role since man existed. Red Indian cures and Essiac, the Hoxsey formula for skin cancers and more, Indian Ayurvedic medicine and compounds such as Carctol. In almost every case that icon has covered, the ‘quacks’ potions’ which were originally dubbed useless have subsequently been shown to contain herbs with anti-cancer properties. Alan took us through the specific proven benefits of many herbs – after all, again, he is a qualified expert in this field. Follow this link for more details.

Diet3
At icon we always stress that supplements should be natural. Sadly the way the new EU laws have been interpreted, many natural supplements will fall by the wayside, and only synthetic ones (which seem to do less well in research) will be allowed on the high streets.

c) Avoiding the dangers

Surely, if you have cancer, it is wiser not to continue to smoke?  Why then would it not be wiser to avoid increasing your oestrogen, insulin or IGF-1 levels?

If that means cutting down on dairy and red meat, then so be it.  Indole 3 Carbinol (broccoli and cabbage) has been used since Roman times with cancers; research shows it converts aggressive oestradiol into oestrone.  Melatonin supplementation is also known to reduce aggressive oestradiol and is used in the treatment of breast cancer.  Hormones in meat, toxins in meat fats and animal fats, IGF-1 in dairy have all been shown to boost oestradiol levels.

Which brings us to the subject of pesticides and organic food.  Readers of David Broom’s article will know that the Environmental Working Group in Washington has shown that certain foods are sprayed more, whilst others retain more pesticide.  Conversely, others are much safer and do not warrant the expense of purchasing the organic equivalent.

Again in Cancer Watch, we covered US research in 2006 that showed how just five days on organic food removed a number of nasties from the bodies of the children in the study.

Some pesticides are oestrogen mimicking chemicals, once inside the body. Lindane and DDT have been directly linked to breast cancer and their use stopped in the Western World. Unfortunately the Pharmaceutical companies still make both and they are still used in certain third world countries. All this at a time our own FSA is reporting that levels of pesticides on imported food are above our UK limits (but they are still allowed onto the High Streets!) If Doctors treat certain breast cancer patients by cutting their oestrogen production, doesn’t it make sense at the same time to cut out the chemicals that can add to the oestrogen ‘pool’ in the body?

The dangers of pesticides are made clear in two articles by experts on our website – Georgina Downs, UK Pesticides Campaign and Andre Leu, Chair of the Organic Federation of Australia

d) Preventing recurrence

A friend of mine has colon cancer. Her oncologist has treated this, but she is frightened it will return.  A precursor to cancer is inflammation and the growth of intestinal polyps.  Certain factors (including foods) are known to aggravate the situation, whilst others have been proven to keep polyps under control.  To date, my friend’s top oncologist has not mentioned diet, nor talked about polyps.

There is a lot of research, including a Nobel Prize, for work that shows salicylin (aspirin, aloe vera), long chain omega 3 (fish oils), garlic, ginger and curcumin can reduce the inflammation and polyp growth.  Further studies confirm the importance of vitamin D and, to a lesser extent, B vitamins like folic acid.  Other studies, including clinical trials, show the importance of beneficial bacteria in the breakdown of dangerous products and the production of helpful ones, some even showing the reduction of risk of recurrence.

A US study over a thirty-year period, covered in Cancer Watch confirmed that people who took a multivitamin at least four times per week had 40 per cent less colorectal cancer.

Isn’t it actually neglect of duty and responsibility for top oncologists dealing with intestinal cancers not to be experts in nutrition?  Why do they not have professional nutritional qualifications?  Why do they not give advice that is very clear from the volumes of research available?

Why cannot oncologists recommend a naturopath or a nutritionist? Except that they would be acknowledging that someone had skills and knowledge beyond their own.

While Harvard, MD Anderson, UCLA and others routinely provide research on vitamins, minerals and supplements, we pooh-pooh them. Back in 2001, John Boik of the MD Anderson Center, Texas, wrote a book entitled Natural Compounds in Cancer Therapy.  It included over 4000 scientific references and should be compulsory reading for all doctors at medical school. Sadly, doctors in the UK hardly receive any education on diet and nutrition during their seven years training. My local GP not only had never heard of lycopene – he even asked how to spell it!

Our view is similar to Boik’s – there is no one cause of cancer, and nor will there ever be one ‘cure’; one ‘magic bullet’. Diet programmes need to be scientifically built so that certain foods with certain proven properties address each stage in the cancer process – Boik defined 20 such stages and put the relevant foods and supplements against each.

The cheapest shot that critics frequently use is that this ‘diet’ or that supplement claims to be a ‘cure’ for cancer and then they pour derision onto it. No professional in the Diet and Nutrition arena would ever claim that a particular diet is a cancer cure – there is no single cure for cancer. All cancer. And, despite the claims of the Press Releases sitting on my desk, Herceptin, Temozolomide and radiotherapy are not ‘cures’ for cancer either!

Mind over Matter

Taking charge of one’s own life is vitally important to some people and doctors ignore this all too frequently when they belittle (yes, they do – we receive the letters!) their patients and their exercise or diet regimes, the hands-on-healer, the Indian head massage, the switch to soya, the findings on the internet, and even the desire for a second opinion.

The mind is an important weapon in the fight to beat cancer. And there is scientific evidence on the role of food here. To give one example, people who are depressed get more cancers, and cancer patients often suffer depression – it is linked to a lowered blood oxygen level. But we know certain foods can help significantly in this area. In 2005 and 2006 there were a number of US studies that showed fish oils were more effective at dealing with depression than even the best ‘clinically approved’ drugs – and they don’t have the side effects. Diet is most definitely a factor in someone’s mental well-being.

On Reflection

That a good diet – providing vitamins and minerals, and avoiding potential dangers – coupled with corrective supplementation using vitamins (e.g. vitamin D), minerals (like magnesium and potassium), antioxidants and certain anti-carcinogenic herbs can help a cancer patient is without question as far as nutritional experts are concerned.

The critics, of course, argue that – without hard numbers and clinical trials – the evidence is not there.  But time and time again this office receives stories – yes, anecdotes – of diets, and diet therapies making a big difference. Professor Baum, also of UCL, calls this the Urban Myth – that someone ‘given six months to live beats all expectations and survives ten years’. He implies that it’s a factor of averages – there will always be people who ‘beat the norm’. But I don’t know. I think that argument is a bit of a cop-out.

Can you ignore the anecdote?  Too small to look into?  What if there are only 150 or so people each year who gain a real benefit from changing their diet?

As we reported in Cancer Watch, the Herceptin trials for early diagnosis in Breast Cancer have been a huge success.  At £20,000 per annum, the mathematic extrapolation of the UK trials indicate that 150 lives will be saved.

We are very supportive of Herceptin.  We are very supportive of diets and diet therapies too. Each has their place in a sensible multi-step and integrative battle to beat cancer.

The icon Diet?

Consider the following, every single point of which has featured in research in icon:

1. Only eat whole grains like whole oats, complete brown rice and barley or millet.
2. Eat at least five lots of vegetables per day, especially greens, reds, purples and yellows.
3. Eat at least two portions of fruit – but only on an empty stomach, first thing in the morning.
4. Eat pulses like beans and lentils at least three times per week.
5. Eat fresh nuts and seeds (especially pumpkin, sunflower and linseeds).
6. Do not fry, or roast at high temperatures.  Grill or steam where possible.  Eat at least one raw meal per day.
7. Eat five to six small meals per day, not one or two big ones.
8. Use only unsaturated oils like olive oil or walnut oil.
9. Restrict your use of salt.  Cut out all processed, prepared, tinned and packaged foods.  Avoid crisps, peanuts, sausages, bacon, soy sauce and other condiments, and especially Chinese food with mono-sodium glutamate.
10. Limit your consumption of red meat and focus on oily fish and on organically farmed meats with less added drugs/pesticides.
11. Avoid all dairy, especially if your cancer is hormonally driven (breast, prostate, colon, etc)
12. Avoid all glucose – especially sweet fizzy drinks.
13. Drink 3 – 4 cups of green tea per day; a glass or two of red wine per week.
14. Take a daily probiotic or two – with ideally several different strains of bacteria.
15. Supplement (but make sure they are natural where possible)

- Take a quality multivitamin and mineral, preferably in a liquid format.
- Take antioxidants (such as beta-carotene, ‘total’ vitamin E, vitamin C, zinc and selenium – ideally in a natural form eg. Chlorella for beta-carotene), but beware doubling up with the multivitamin
- Take vitamin D and fish oils.
- Consider coenzyme Q10 and curcuma longa.
- Look into taking Herbshield (it will have to be prescribed by a professional herbalist)
- If the cancer is hormonally driven,
i. Consider taking red clover and/or soya isoflavones plus Indole 3 Carbinol.
ii. Consider melatonin supplementation (Asphalia is a natural alternative).
Diet4

Tags: , , ,

Building An Integrated Cancer Treatment Program

Originally published in August 2002 icon, updated in October 2003 icon

Building An Integrated Cancer Treatment Program

Through The Best Use Of Orthodox, Complementary And Alternative Cancer Therapies

Image montage

In one of the first editions of icon, we ran a centrefold entitled “Cancer – Your 15 First Steps”. We received hundreds of telephone calls from people eager to build themselves an integrated treatment programme that gave them the best odds of survival. Some of the steps had been unknown to them or their advisors.

Open quotesRemember, on average, three out of four people win the battle with cancerClose quotes

We continue to receive phone calls at icon from people who want to do more than simply rely on ‘orthodox’ treatments, however excellent these may be. But right up front we wish to make two points crystal clear:

1. We are advocates of well-researched, integrated Complementary and Alternative Treatments in order to give patients the very best chances of beating this terrible disease. On this website you will find objective comment on a variety of therapies, with research evidence if it exists. We will always try to separate fact from mythology, research evidence from overclaim and speculation. Cancer patients (and their supporters and advisers) need information sources they can trust.

2. We aim merely to lay out the options, not to pass judgement on which you should choose. Our view is that there is so much information and knowledge about what can work, but that a great deal of it is neither collected properly nor passed on. We feel that an important part of this magazine is to pass on the facts about what can help you in your quest to increase your chances of survival

Your First 15 Steps Cover

Accordingly, we decided to build a service for cancer patients in two parts:

(a) A book of no more than 100 pages that would give them a simple guide on how to plan such a programme.

(b) A consultancy service of doctors, nurses, biochemists, nutritionists plus complementary therapists, purely to explain the options available in an objective way and provide information with reference to its sources.

The former is called “Cancer - Your First 15 Steps” and includes the Active8 programme; eight practical things every cancer patient must focus on.

The latter is a unique service we have launched in 2006 – a personally tailored information service for you and your cancer. It is called a Personal Prescription and it will provide you with the information you need to build your own integrated programme of Complementary therapies around your doctor’s expertise. And it will give you access to all manner of relevant information saving you months of searching around the net.

Open quotesBe determined. Don’t be a victim. Be
a victor.Close quotes

But our grandest long-term scheme is that ideally we want all doctors in the country to give out the book “Cancer – Your First 15 Steps” at the moment of diagnosis – that’s a mission of CANCERactive. Who knows? One day perhaps, we can only hope.

You’ve been diagnosed with cancer, amidst the fear, the unknown and even the cold panic you need to give yourself the best chance of winning the battle.

Remember, on average, three out of four people do.

Don’t be average. Be much better than that.

Be determined. Don’t be a victim. Be a victor.

Research shows that those people who build a total, holistic programme, have good support, people who fight – these people build themselves a 60 per cent extra survival advantage.

A: The Basics

1:

Get a buddy

Do not tackle this problem alone; find a fit healthy caring family member or friend you will help you throughout. Someone you can talk with, who will help find out things for you; someone who wants the best for you. Someone who will ensure you go to all your treatments.

2:

Seek knowledge

There’s a saying ‘knowledge is power’. In cancer, it can be the difference between life and death. Seek information and knowledge.

Have an open mind and look for hard data on effacacy.

Recommended links -

http://www.gersonplus.com Dr. Dan Rogers

http://www.cancerdecisions.com Dr. Raplh Moss

http://www.icrpstudy.com Researcher Fred Bishop

3:

Work with your doctor

Your doctor should be your best ally as you seek the very best programme of treatment for yourself. Tell him what you want to achieve, and ask him to participate fully – if he doesn’t know the facts and benefits of a complementary therapy, ask him to be honest with you, not dismissive of it.

4:

Get a second opinion

It’s your life and there is never one way of treating the cancer. Maximise your information and your options.

Open quotesResearch shows that those people who build a total, holistic programme, have good support and who fight build themselves a 60% extra survival advantageClose quotes
5:

Write a plan

Start to prepare a good plan. What treatment and when – the best course of action? Write it down and discuss it with your buddy and your doctor. When you are happy with it – give it 110 per cent commitment.

6:

Be prepared to change

Something about your lifestyle, diet or living habits may well have ‘triggered’ this cancer. If you don’t vow to change, there is no reason why the cancer will not return at some stage. Also, how can you find the solution if you don’t address the problem?

7:

Find out if your cancer is hormonally driven

Men (yes really) and women often have solid tumours that are hormonally responsive. Prostate, breast, colon cancers and melanoma are examples.

At the root is excess oestrogen – even in men – and much can be done to cut oestrogen and its mimics out of your life. You can find out more with another of our mini books ‘Oestrogen – the killer in our midst

8:

Oxygenate your cells

Exercise and deep-breathing fresh air will get oxygen to your cancer cells. And they hate it!

9:

Detoxify your cells

Look for the possible cause of your cancer; Smokingdiesel fumes, radon, radiation, viruses, parasites, mercury, pesticides, herbicides, sunshine etc.

Stop poisoning your cells. Cut salt and dairy; build potassium and magnesium foods. Alkalise your body.

10:

Control your weight

Fat stores toxins, and fatter people are more toxic. Research shows clearly that being overweight is linked to more illness, more cancer and a shorter life.

11:

Love your immune system

12:

Kick out the parasites

Top clinics in Britain and America are adamant. Cancer patients always have a parasite; it could be a fluke, but more likely a microscopic microbe, a virus, bacterium or a yeast especially candida – and that goes for men or women.

Open quotesThere’s so much information out there – don’t die of ignoranceClose quotes
13:

Boost your body energy

The Russian, Kirlian, has taken pictures of individual human auras, and NASA scientists have done endless research, yet your doctor may be totally ignorant, or dismissive of chakras and body energy.

Acupuncturists and Cranial Osteopaths can help you, healers and Reiki masters too. Your body energy is totally linked to your brain, your hormones and the physical state of your cells. Ignore it at your peril.

14:

Surround yourself with warmth and happiness

Surround yourself with positive people – lose the negative ones. This is your new support group. Watch comedy shows and your favourite programmes. Laugh. Make 5 new friends.

Tufts Cancer Centre noticed that patients with a God survived seven times longer – does this fact need explaining?

15:

Find the real you

Change your mind set. Be true to yourself. What do you want to do with your life when you’ve beaten the cancer? OK. So go on and do it. What are you waiting for?

Be true to yourself. Be true to your soul - the real you.

Cancer – Chemotherapy and Anti-Oxidants

Originally published in icon Issue 4 2006

Anto -o

Increasingly, the orthodox medical world is demanding that all cancer therapies must have scientifically based research evidence to support their use. The ‘gold standard’, often quoted, is largely limited to chemotherapy drugs and is called the ‘Clinical Trial’.

At icon we agree with this need.  Unfortunately, less clear is which types of research are acceptable.  Scientists attempt to produce hard evidence on the successful performance of a drug, citing how many people in a trial group had a positive effect against an identical group taking (unknowingly) a placebo.  Various other controls are incorporated to rule out unwanted outside influences.

Open quotes accurate measurements of the negative side effects of a drug are every bit as important as measuring the benefits Close quotes

However the rigour of exactly how many people benefit from the drug often falls woefully short when the issue of side effects is considered. These are most usually ‘touched upon’ rather than provided as accurate percentages in the same way the benefits are measured. We have covered (in a previous issue – Vol 2 ; 2006) the concerns expressed by experts in the Lancet Oncology magazine of the negative effects of, say, monoclonal antibodies. As we have expressed before inicon, accurate measurements over a sensible period of time of the negative side effects of a drug are every bit as important as measuring the benefits. Furthermore, in some cases, euphoria on the positive findings is seeing some drugs pulled out of Clinical Trials before they have even completed their allotted time span.

anti-o2The other problem with the use of ‘hard scientific evidence’ is that, all too often, papers are presented by ‘interested parties’ with a resultant bias. Again, in 2004 and 2005 two ‘megastudies’ of anti-oxidants were covered in this magazine. In response to a concern expressed by Professor Tony Howell, one of our charity patrons, we analysed the data to find, for example in one case with vitamin E, that far from being a ‘megastudy’, the scientists had only looked at 14 studies, (far less than we considered for our own report on vitamin E) and far from looking at the naturalvitamin in its 4 tocopherol forms or its 4 tocotrienol forms, the only research taken by the scientists was for the synthetic vitamin E in solely the alpha-tocopherol form. (Which, for example, has virtually no proven benefit with breast cancer, unlike the tocotrienol forms). From this they managed to conclude that ‘vitamin E could actually increase your risks of dying by 10-30%’. Poor research at best (Cancer Research UK agreed with us), but possibly by co-incidence, it was published shortly before the decisions in the EU were to be made on whether vitamins should be treated as drugs and which would be permitted for sale in the shops. In Cancer Watch we cover research, again from the Lancet, on how ‘vested interest’ research is reducing the credibility of Doctors and Specialists alike amongst the general public.

A further problem occurs in providing information on research and doctors.  In icon we previously reported on the senior Australian Government Medical Advisor who has set up a website for doctors on pharmaceutical clinical trials, listing all benefits and side effects, because he was so concerned that ‘doctors only get that information from PR releases and media coverage, both of which are provided by the pharmaceutical companies themselves and may be biased’.

Doctors don’t get time to read endless research reports and, anyway, outside the area of drug clinical trials lie a minefield of different types of research and, often subjective, opinion.

As an example, one of the most commonly asked questions by people ringing our offices is, ‘Should I be taking my anti-oxidants when I have chemo or radiotherapy?’

Our answer is a categoric, ‘YES’. Hitherto we have read the ‘tome’ by John Boik, one of the senior staff at the prestigious MD Anderson Cancer Centre in Houston, Texas. This book is over an inch thick, published in 2001 and called ‘Natural Compounds in cancer therapy’. It contains over 4000 references to scientific papers and basically concludes that, far from in some way interfering with the biochemical process involved in chemo or radiotherapy, taking anti-oxidants actually improves the success rates of both. Support for this stance came in 2005 – again covered in icon Cancer Watch, when UCLA produced the conclusion that healthy cells are self regulators and will pick up the maximum concentrations of anti-oxidants available in order to maximize their biochemical processes. However cancer cells have lost most of this regulatory ability and will overload on anti-oxidants. Their view is that this will help the chemo or radio ‘kill them off’.

Open quotes a number of oncologists adamantly tell their patients that they do not want them taking anti-oxidants during their chemo or radiotherapy …….but requests for ‘hard scientific research evidence’ supporting the oncologist’s concern have come to nothing Close quotes

The problem for us, and especially for the cancer patients who call us, is that a number of oncologists adamantly tell their patients that they do not want them taking anti-oxidants during their chemo or radiotherapy as this will somehow weaken the effect. Patients are thus ‘scared’ into dropping their supplementation programmes. Our problem is compounded because we are very open minded on this issue still, but frequent requests to be sent the ‘hard scientific research evidence’ supporting the oncologist’s concern have come to nothing. We would be happy to print it. But does any actually exist, or is the concern pure subjective opinion and mythology?

In September 2005 a paper was actually published in the USA in A Cancer Journal for Clinicians (Gabriella D’Andrea MD). More of an article than a genuine scientific paper, it warned against using anti-oxidants with chemo and radiotherapy. However by chance, or oversight, it missed all the papers supporting anti-oxidants, used only clinical laboratory research rather than human or epidemology

Open quotes specific and synthetic anti-oxidants areapproved by the FDA and recommended for use with chemotherapy Close quotes

studies, and omitted the fact that in certain cases (e.g. the use of amifostine) some specific and synthetic anti-oxidants are approved by the FDA and recommended for use with chemotherapy and are known to have enhancing benefits in, say, oral and lung cancers and child leukemia. icon, for example, carried clinical research in 2004 that vitamin E supplementation could produce the same positive effects from Tamoxifen, at a 25  per cent lowered drug dosage. Great for the patient – but not so great for the profitability of the pharmaceutical company concerned. We doubt any oncologist has even noticed the research.

anti-o3

The D’Andrea article did, however, re-open the debate about taking anti-oxidants with chemotherapy and radiotherapy.

The whole matter has recently been highlighted by Ralph W. Moss PhD, the famous US cancer researcher. In a paper ‘Should patients undergoing Chemotherapy and Radiotherapy be prescribed antioxidants? (Integrative Cancer Therapies Vol 5, 1; 63-82.http://ict.sagepub.com/cgi/reprint/5/1/63. Also on PubMed) Moss expertly takes the reader through the myriad of research, including clinical trials, stating clearly that the D’Andrea paper was incomplete and that there is far more information available than either she included or is widely acknowledged. His conclusion is that a ‘blanket rejection of the concurrent use of anti-oxidants with chemotherapy is not justified by the preponderance of evidence’. For the more scientifically biased amongst our readers we have listed below some of the main scientific references on this subject.

Open quotes If taking anti-oxidants is of such a concern, why do many of the same oncologists tell the patient to eat plenty of fresh fruit and vegetables instead? Close quotes

Moss raises another important point – one we have repeatedly made. If taking anti-oxidants is of such a concern, why do many of the same oncologists tell the patient to eat plenty of fresh fruit and vegetables instead? Is it because they believe fresh fruit and vegetables are devoid of anti-oxidants these days and thus can’t interfere with their chemotherapy? Or is it because they are fearful of the synthetically produced ones? (Just as we are – you’ll note in icon we continually tell you to take the natural forms). Perhaps it is neither of these. Perhaps they are just not aware of the enormous amount of research in the US alone.  However, the answer may lie in an article from the early days of icon, when Dr. Graham Henderson wrote a piece for us telling our readers just why UK Doctors were so negative towards complementary therapies. To summarise: UK Doctors want to be the fount of all knowledge for their patients, and many have neither studied formally, nor had the time to study since leaving medical school, these complementary therapies and especially nutrition. (Only recently a newly qualified doctor was in our offices openly stating that (apart from a morning on combating heart disease) she had not spent one day formally studying nutrition in her whole seven years training!) As Dr. Henderson concluded, most UK Doctors are outside their both knowledge and comfort zones.

Nothing brings this home more than reading Moss’ conclusions, one of which is that ‘Patients would be well advised to seek the opinion of physicians who are adequately trained and experienced in the intersection of 2 complex fields, that is, chemotherapy and nutritional oncology’.

If all UK NHS oncologists who qualify e-mail us on enquiries@canceractive.com with their name, phone number and qualifications we will happily publish a list in the magazine and on our web site. This debate will not be settled until we have more experts who are fully qualified in both oncology and nutritional therapy.

Meanwhile, a similar view on the benefits and the increasingly vacuous criticism of natural compounds as beneficial adjuncts to chemo and radiotherapy can be found in the article on Herbs by the expert Alan Hopking in icon Issue 3 2006.

For the record, we continue to recommend that all patients having chemo and radiotherapy supplement using natural supplements (like Chlorella, garlic, astragalus, Aloe Vera, medicinal mushrooms, natural vitamin E etc) as we increasingly find positive research-based evidence.  (For example:  Prasad K. N:  Int. Cancer Therapies 2004, 3:3, 310-323.  Multiple dietary antioxidant therapies enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. But we especially recommend that patients load up on the foods that can provide them with the biggest range of cancer fighting agents possible.

Open quotes Rainbow diet At Last – the definitive, research based book on how to build a diet to help beat cancer. Click here to read about it. Close quotes

References:

For those of you who want to check the scientific references used, we have selected a mere 75 from those recorded by Ralph Moss

************************************************************************

Some detailed references:

  • D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin. 2005;55:319-321
  • Parker-Pope T. Cancer and vitamins: patients urged to avoid supplements during treatment. Wall Street Journal. September 20, 2005:D1.
  • Cohen MH. Complementary and Alternative Medicine: Legal Boundaries and Regulatory Perspectives. Baltimore, Md: Johns Hopkins University Press; 1997.
  • Moss RW. Antioxidants Against Cancer. Brooklyn, NY: Equinox Press; 2000.
  • Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integr Cancer Ther. 2004;3:310-322.
  • Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer. 2000;37:1-18.
  • Conklin K. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 2004;3:294-300.
  • Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. Gammatocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci USA. 2004;101:17825-17830.
  • Ferrari CK. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology. 2004;5:275-289.
  • Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol. 2003;88:434-439.[CrossRef][Medline] [Order article via Infotrieve]
  • Chen Q, Espy MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A. 2005;102:13604-13609.[Abstract/Free Full Text]
  • Paiva SAR, Russell RM. Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr. 1999;18:426-433.[Abstract/Free Full Text]
  • Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys. 2001;385:20-27.[CrossRef][Medline] [Order article via Infotrieve]
  • Bairati I, Meyer F, Gelinas M, et al. Randomized trial of anti-oxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol. 2005;23:5805-5813.[Abstract/Free Full Text]
  • Bairati I, Meyer F, Gelinas M, et al. A randomized trial of anti-oxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 2005;97:481-488.[Abstract/Free Full Text]
  • Camphausen K, Citrin D, Krishna MC, Mitchell JB. Implications for tumor control during protection of normal tissues with antioxidants. J Clin Oncol. 2005;23:5455-5457.[Free Full Text]
  • Block K. Antioxidants in the news. Integr Cancer Ther. 2005;4:271-273.[Free Full Text]
  • Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med. 1979;301:687-690.
  • Moertel CG, Fleming TR, Creagan ET, Rubin J, O’Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med. 1985;312:137-141.
  • Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-537.[Abstract/Free Full Text]
  • Memorial Sloan-Kettering Cancer Center. Cancer tumors shown to consume large amounts of vitamin C [press release]. September 15, 2000. Available at: www.mskcc.com.
  • Newbold HL. Vitamin C Against Cancer. New York, NY: Stein & Day; 1979.
  • Gonzalez MJ, Miranda-Massari JR, Mora EM, et al. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32-44.[Abstract/Free Full Text]
  • Jaakkola K, Lahteenmaki P, Laakso J, Harju E, Tykka H, Mahlberg K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res. 1992;12:599-606.[Medline] [Order article via Infotrieve]
  • Lesperance ML, Olivotto IA, Forde N, et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat. 2002;76:137-143.[CrossRef][Medline] [Order article via Infotrieve]
  • Alam N, Shepherd FA, Winton T, et al. Compliance with postoperative adjuvant chemotherapy in non-small cell lung cancer: an analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer. 2005;47:385-394.[CrossRef][Medline][Order article via Infotrieve]
  • Hoffer A. Comments on “Mega-Dose Vitamins and Minerals in the Treatment of Nonmetastatic Breast Cancer: An Historical Cohort Study.” Integr Cancer Ther. 2003;2:155-157.[Free Full Text]
  • Conklin K. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther. 2005;4:110-130.[Abstract/Free Full Text]
  • Bertazzoli C, Sala L, Ballerini L, Watanabe T, Folkers K. Effect of adriamycin on the activity of the succinate dehydrogenasecoenzyme Q10 reductase of the rabbit myocardium. Res Commun Chem Pathol Pharmacol. 1976;15:797-800.[Medline] [Order article via Infotrieve]
  • Cortes EP, Gupta M, Chou C, Amin VC, Folkers K. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat Rep. 1978;62:887-891.[Medline] [Order article via Infotrieve]
  • Brash DE, Havre PA. New careers for antioxidants. Proc Natl Acad Sci U S A. 2002;99:13969-13971.[Free Full Text]
  • Shin DM, Khuri FR, Murphy B, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol. 2001;19:3010-3017.[Abstract/Free Full Text]
  • Seixas-Silva JA Jr, Richards T, Khuri FR, et al. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2005;131:304-307.[Abstract/Free Full Text]
  • Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003;21:927-931.[Abstract/Free Full Text]
  • Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology. 2005;64:26-31.[Abstract/Free Full Text]
  • Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol. 2003;21:2545-2550.[Abstract/Free Full Text]
  • Delanian S, Depondt J, Lefaix JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck. 2005;27:114-123.[CrossRef][Medline] [Order article via Infotrieve]
  • Pathak AK, Bhutani M, Guleria R, et al. Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr. 2005;24:16-21.[Abstract/Free Full Text]
  • Kennedy M, Brunuinga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol. 2001;96:1080-1084.[CrossRef][Medline] [Order article via Infotrieve]
  • Mahmoud F, Sarhill N, Mazurczak MA. The therapeutic application of melatonin in supportive care and palliative medicine. Am J Hosp Palliat Care. 2005;22:295-309.[Medline] [Order article via Infotrieve]
  • Jang MH, Jung SB, Lee MH, et al. Melatonin attenuates amyloid beta 25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett. 2005;380:26-31.[CrossRef][Medline] [Order article via Infotrieve]
  • Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res. 2003;35:12-15.[CrossRef][Medline] [Order article via Infotrieve]
  • Cerea G, Vaghi M, Ardizzoia A, et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res. 2003;23:1951-1954.[Medline] [Order article via Infotrieve]
  • Lissoni P, Malugani F, Bukovec R, et al. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients. Neuro Endocrinol Lett. 2003;24:83-85.[Medline] [Order article via Infotrieve]
  • Lissoni P, Bucovec R, Bonfanti A, et al. Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia. J Pineal Res. 2001;30:123-126.[CrossRef][Medline] [Order article via Infotrieve]
  • Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol. 2000;21:513-520.[Medline] [Order article via Infotrieve]
  • Miyajima A, Nakashima J, Tachibana M, Nakamura K, Hayakawa M, Murai M. N-acetylcysteine modifies cisdichlorodiammineplatinum-induced effects in bladder cancer cells. Jpn J Cancer Res. 1999;90:565-570.[Medline] [Order article via Infotrieve]
  • Bohm S, Oriana S, Spatti G, et al. Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma. Oncology. 1999;57:115-120.[CrossRef][Medline] [Order article via Infotrieve]
  • Smyth JF, Bowman A, Perren T, et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol. 1997;8:569-573.[CrossRef][Medline] [Order article via Infotrieve]
  • Cascinu S, Catalano V, Cordella L, et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2002;20:3478-3483.[Abstract/Free Full Text]
  • National Cancer Institute. Overview of nutrition in cancer care. June 17, 2005. Available at:http://www.cancer.gov/cancerinfo/pdq/supportivecare/nutrition
  • Ladner C, Ehninger G, Gey KF, Clemens MR. Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen. Cancer Chemother Pharmacol. 1989;25:210-212.[CrossRef][Medline] [Order article via Infotrieve]
  • Clemens MR, Ladner C, Ehninger G, et al. Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr. 1990;51:216-219.[Abstract/Free Full Text]
  • Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park). 2005;19:371-379.[Medline] [Order article via Infotrieve]
  • Lissoni P, Paolorossi F, Ardizzoia A, et al. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res. 1997;23:15-19.[Medline] [Order article via Infotrieve]
  • Yu D, Duan Y, Bao Y, Wei C, An L. Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate. J Ethnopharmacol. 2005;98:89-94.[CrossRef][Medline][Order article via Infotrieve]
  • Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005:CD004540.
  • Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J, Kelly KM. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer. 2005;44:378-385.[CrossRef][Medline] [Order article via Infotrieve]
  • Kennedy DD, Tucker KL, Ladas ED, Rheingold SR, Blumberg J, Kelly KM. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr. 2004;79:1029-1036.[Abstract/Free Full Text]
  • Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol. 2004;54:469-473.[CrossRef][Medline] [Order article via Infotrieve]
  • Ozcan A, Korkmaz A, Oter S, Coskun O. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol. 2005;79:461-465.[CrossRef][Medline] [Order article via Infotrieve]
  • Food and Drug Administration. Zinecard (dexrazoxane for injection). NDA 20-212/S-008. Available at: http://www.fda.gov/medwatch/safety/2005/MAY_PI/Zinecard_PI.pdf.
  • Food and Drug Administration, Center for Drug Evaluation and Research. FDA oncology tools approval summary for dexrazoxane for reducing the incidence and severity of cardiomyopathy, October 31, 2002. Available at:http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=256.
  • Hensley ML, Schuchter, LM, Lindley, C, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999;17:3333-3355.[Abstract/Free Full Text]
  • Marzatico F, Porta C, Moroni M, et al. In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol. 2000;45:172-176.[CrossRef][Medline] [Order article via Infotrieve]
  • Kemp G, Rose P, Lurain J, et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. JClinOncol. 1996;14:2101-2112.[Abstract/Free Full Text]
  • Food and Drug Administration, Oncology Division Advisory Committee. Fulfillment of the accelerated approval requirements for the non-small cell lung cancer indication: ethyol (Amifostine) reduces the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced non-small cell lung cancer. Available at:http://www.fda.gov/ohrms/dockets/ac/03/briefing/3936B1_05_MedImmune-Eythol.htm.
  • Schiller JH. High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer. Semin Oncol. 1996;23:78-82.[Medline] [Order article via Infotrieve]
  • Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18:3339-3345.[Abstract/Free Full Text]
  • Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351:145-153.[Abstract/Free Full Text]
  • Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88:1550-1559.[CrossRef][Medline] [Order article via Infotrieve]
  • Food and Drug Administration. Gefitinib (marketed as Iressa) information. 2005. Available at:http://www.fda.gov/cder/drug/infopage/gefitinib/default.htm.
  • Mosman Communications, Inc. Industry news: AstraZeneca posts US$21B sales. Medical Observer. May 15, 2005. Available at:http://www.medobserver.com/mar2005/indnews.html.
  • Lissoni P, Barni S, Brivio F, Rossini F, Fumagalli L, Tancini G. Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study. J Biol Regul Homeost Agents. 1995;9:52-54.[Medline] [Order article via Infotrieve]

Tags: , , , ,

Nutrition Plays a Critical Role in Cancer

Chris Woollams presents an argument against chemotherapy. The reply, by the medical profession, can be found here.

Hospital Pass

Open quotesAll the patients in the ward are dying of cancerClose quotes

I’m sitting in a room in a Hospice. My daughter is asleep with her brain tumour. But in the last few days I have had several interesting conversations.

All the patients in the ward are dying of cancer. In Catherine’s case her oncologist has said that there is nothing more he can do and so he has passed her on to palliative care and the Hospice. I suppose I should accept that, at this stage, all bets are off, but it’s not in my nature to sit back idly and no longer try. I even turned the radio on yesterday and the first words I heard were ‘never give up, never give up’ in a pop song. Spooky.

But Catherine drinks her Ribena, has a breakfast of Rice Crispies or Bran Flakes with milk and eats the excellent fish in cream sauce, and ice cream, all provided by the NHS.

Junk food

A sense of ‘deja vu’ passes over me. Earlier in the year two readers sent in a booklet from The Royal Marsden which provided information on what patients should eat whilst having chemotherapy. So alarmed were we by the recommendations featuring cancer-fuelling high levels of fat, sugar and salt – the booklet even showed pictures of milk shakes, cheeseburgers and doughnuts – we asked ten different cancer centres to give us their views. In the Royal Marsden’s defence we discovered that their dieticians were so overworked they only had time for about 7-10 per cent of all patients; always those who were losing weight fast and thus their diet recommendations were specifically designed to tackle these extreme cases. However, the booklet still went out toall chemo patients.

But I do wonder, and worry. When Catherine ‘came-to’ after a brain tumour operation in February, her hospital diet again was dairy and sugar-based.

Let’s get it straight. As any half decent biochemist will tell you

  • Glucose is the favourite food of a cancer cell. Ribena has four times the sugar of coca cola. Glucose fuels cancer and we’ve known this since 1931. Worse, new research has shown that within 15 minutes of eating sugar certain areas of the immune system can be depleted by up to 90 per cent!
  • Dairy contains IGF1 and this has been known to help propagate cancers since 1992.
  • Salt (sodium) helps imbalance your cellular power stations by displacing potassium. It powers them down and encourages a state favoured by cancer cells.

Why don’t hospital cooks know this?

Myth and Reality

Open quotesGlucose fuels cancer and we’ve known this since 1931Close quotes

Certainly the nurses did not know, but they were very keen to learn. All unanimously praised icon for its information and its breadth – they like the fact that it covers diet and chemotherapy, supplements and radiotherapy equally and open-mindedly.

As the discussions developed, we got on to subjects like B-17. As readers know, I am neither ‘for’ B-17 nor ‘against’ it. I am completely open-minded and I believe it is time to research it properly in a fair and unbiased way. We all need to know the truth. The standard criticism of B-17 is that ‘it contains cyanide’. But then so does vitamin B-12 and no one in their right mind is suggesting we ban vitamin B-12 in the UK. It is essential to over 300 biochemical pathways. In some quarters, ‘experts’ claim that there is no evidence that B-17 works to kill cancer cells. But, in fact there are 5 studies – on animals and humans – saying it does.

Some ‘experts’ say that this cyanide content of B-17 means it is dangerous and could kill people. So where is the factual evidence of B-17, when properly administered by qualified doctors, showing the side effects of killing people? What percentage does it kill? Again we’d simply like to pass this on to our readers.

Open quotesWe all need to know the truthClose quotes

The same scenario goes for The Gerson TherapyMistletoe,Hydrazine Sulphate etc. etc. etc. (Mistletoe has thorough clinical trials in Germany, Hydrazine Sulphate in Russia yet these seem generally ignored in the USA and UK).

So increasingly in the UK – in the absence of any full and proper data on such alternative or complementary therapies – we are herded down a tunnel labelled “Surgery,Radiotherapy and Chemotherapy“.

And here’s the rub. Catherine’s five nurses had a number of views on chemotherapy. Broadly they were in three areas.

  • There are a number of new drugs which are supposed to be wonderful (they couldn’t name any)
  • The drugs they use now have some terrible side effects
  • Doctors don’t really know about this because they don’t come often enough to the coalface!

Side Effects

Cod live oil

Recently there have been a number of press reports about the use ofComplementary Alternative Medicines, such as fish oils and herbs and how people taking these must be careful because of their side effects, especially where they might interact with prescribed drugs. Some people are even proposing restrictions, prescriptions and warning labels.

But when the nurse gives Catherine her eleven pills with her breakfast, are any similar warnings given to Catherine on side effects? What is known about the interaction of the four or five different types of drug? Have there been trials conducted on this concoction? Of course not; just on the individual elements.

As an ex-advertising man you would expect me to want drugs to be advertised on TV. But, in fact, a US TV ad for a drug makes the side effect point better than I can ever do. The first 10-12 seconds of the ad tells you what the drug can do for you; the next 15-18 seconds lists the side effects. It’s the law.

Every drug you put in your mouth has a side effect. Fact. And most usually the doctor will try to control that side effect with another drug. That is why some patients take three or four types of drug and why there is no such thing as a poor pharmaceutical company.

Open quotesEvery drug you put in your mouth has a side effectClose quotes

Three and a half years ago, my daughter was ‘given’ six months to live by her oncologist. She had a grade 4 tumour then and he told me a life expectancy of six months was his considered view. The maximum anyone had survived was 18 months. As readers may know, after 12 months her scans kept showing “all clears” and two doctors encouraged me to write the book, Everything you need to know to help you beat cancer.

I was approached for information by someone about her cousin, who also had a brain tumour. By coincidence he was under the same oncologist as Catherine. However he, being rich and ex-city, had sought a second opinion in Dukes Cancer Center in the USA. They told him that the drug doses provided in the UK were too low and he should virtually double them. So he did.

Interestingly in my conversations with him, he told me that every time he went on holiday to the sun (South Africa, Barbados) his tumour stopped growing. Was that rest, relaxation, the effects ofVitamin D? Did anybody look into why this might be so? No.

Open quotesEvery time he went on holiday to the sun his tumour stopped
growingClose quotes

I saw him last at the National Brain Tumour Conference, where I was giving a speech. He was ashen-faced with scabs on his lips. Clearly the chemotherapy was taking a toll on his immune system. However, he said he felt fine and was very positive. He left the conference on the Tuesday, went to watch a golf match with his father on the Thursday, collapsed, and died on the Saturday. His death is recorded as cancer and a brain tumour. He actually died because the drugs caused a haemorrhage in a blood vessel in his brain.

The Urban Myth

Now back in July when some of the medical profession were seeking to rubbish Prince Charles for his comments on The Gerson Therapy, Professor Michael Baum made a number of points (see iconSeptember/October 2004) -

  • That there will always be people who live longer than expected; he called this the Urban Myth.
  • That unless Complementary Therapies (such as Gerson) subjected themselves to the same rigorous standards as drugs have to pass, they would be forever condemned to the peripheries of medicine.

Professor Baum, unfortunately in my opinion, makes it all sound like a special club with clear rules for membership.

Let me make it clear. I am completely behind proper, definitive research, on which to base judgements. My problems are threefold -

  1. That there have been incidences of ‘clinical trials’ on drugs being less than vigorous, side effects hidden, judgements on their conclusions treated over-enthusiastically, but that ‘once approved (for example by the FDA in America), these drugs are accepted, full stop’.
  2. That too often research on complementary and alternative therapies is non-existent, or trivial, or conflicting, (for example – see Cancer Watch on gastro intestinal cancers this month), and this makes it easily criticised.
  3. That the majority of the medical profession thus places its trust in the former and simply dismisses the latter resulting in this vision of drugs as our salvation.
Open quotesSo where has this obedience to chemotherapy and the clinical trial taken us to date?Close quotes

So where has this obedience to chemotherapy and the clinical trial taken us to date?

Complacency Rules

Let me quote you some figures.

1) The National Audit Office has stated in 2004 that over the last 30 years, 5-year survival rates for cancer patients have improved by 12 per cent. What? Only 12 per cent, despite all the money being spent on drugs and treatments?

Certain cancers, for example child leukaemias and testicular, are very treatable by chemotherapy agents. Skin cancers, which have roared into the ‘charts’ in the UK in second place are also very treatable. Where does that leave the rest of the cancers?

Well I’m glad I asked.

2) Accordingly to the National Audit Office, 5-year survival rates vary greatly by cancer type, but we are now in line with Europe. Not true.

Take Breast Cancer, for example:

Checking the breast

In Eurocare-3, the best country was Sweden with about 83 per cent survival, then France and Germany with over 81. Where was the UK? Answer; Around 73 per cent. Below the average for Europe; but reassuringly above the likes of Poland and Latvia.

Try Prostate Cancer; if you dare. Top, Austria at 83 per cent. The UK?Below the average for Europe, at 53 per cent.

In fact, if you want to feel discouraged let’s look at the overall figures:

All men’s cancers (%)

  • Europe Average (40.5)
  • England (37.1)

All women’s cancers (%)

  • Europe Average (53.6)
  • England (50.8)

This is the URBAN MYTH, Professor Baum. That radiotherapy and chemotherapy ‘CURE’ cancer. They don’t.

Open quotesStill we seem destined to merely ape the USAClose quotes

But still we seem destined to merely ape the USA, with more “wonder drugs” and “breakthroughs” almost a weekly occurrence.

Yet the US has 5-year survival rates of only 51 per cent for whites and 48 per cent for blacks.

And the prestigious MD Anderson Cancer Center in Texas is stating quite clearly that, ‘all the exciting developments in cancer are coming in areas other than chemotherapy.’

The Austrians use a number of herbal remedies. In Germany top oncologists are often trainedhomeopaths. They may test their patients with Vega machines to look for allergies, toxins and the like. Which doctors in the UK have even seen a Vega machine? In Germany, if the first treatment doesn’t work, the oncologist has to give you an alternative by law. My local GP in France is also a qualified homeopath and claims he has never given anyone an antibiotic. And France has the best healthcare service in the world according to the WHO (World Health Organisation). When will we open our eyes?

Chemotherapy

The fact is that historically chemotherapy drugs were like dropping a nuclear bomb on Watford because there was a known terrorist cell there. Even then this was no guarantee that one would not have gone to London for the day.

Open quotesPlease don’t get me wrong – I am not anti-chemotherapyClose quotes

Please don’t get me wrong. I am not anti-chemotherapy. If I had testicular cancer, or child leukaemia I would probably have the drugs. If I had pancreatic cancer or a brain tumour I certainly would not. I am simply ‘anti’ the blind faith of the medical profession; the back slapping, pseudo-euphoria that meets a new drug launch; that espouses that somehow drugs cure cancer.

Now there is no doubt that scientists are trying to develop the smart bomb for cancer: The missile that goes down streets, round corners and only hits the house with the terrorists in it. And I’m very happy about this.

Unfortunately while we wait, more innocent victims are suffering, because the majority of the drugs do not actually deliver a ‘cure’, but do deliver a host of debilitating side-effects.

Trials and Tribulations

Hardly a day passes without more claims for yet another wonder drug. The pharmaceutical companies have excellent PR machines, aided and abetted by a few over-enthusiastic scientists and doctors.

Take Professor Alex Markham, chief executive of Cancer Research UK. In an interview in The Times on 20th September 2004 he was positively ecstatic. “It is an extraordinary fact. In 2004 we will put almost 30,000 patients into (drug) trials, while the US does about 25,000. We have never done so well. Survival rates for adult cancers have increased by 1 per cent a year over the last decade (Note: this disagrees with the National Audit figure of 12 per cent in 30 years). We cure 43 per cent of people who develop cancer in this country.”

Open quotesWe cure 43 per cent of people who develop cancer in this countryClose quotes

Oh, heaven and euphoria.

He is worried about three cancers: lungpancreas and oesophagealbut does not mention the rising tide of brain tumours or oestrogen-driven cancers. In the young (where child leukaemia does have effective drugs) he claims we have “gone from 70 per cent dying to 70 per cent surviving”.

“Cure”. “Surviving”. The words just roll off his tongue without hint of their true meaning or the asterisk in the research report that says “for 5 years”. Indeed in children, brain tumours are clearly growing behind leukaemia with no “cure” in sight and little research being done.

Now, it is true that some drugs are accepted as merely life-extenders, for 4 months or 4 years, and no one can dismiss this benefit providing it is not gained at too great a cost.

A further cautionary note was sounded at the European Breast Cancer Conference in 2004 by several scientists who warned that drugs were being rushed onto the market before trials were even finished, whilst “success” claims were being made even earlier.

In breast cancer the “gold standard” is Tamoxifen. It acts to block oestrogen receptor sites. It is known to have serious side effects, so much so that the World Health Organisation has dubbed it a class A carcinogen itself! In California where a fair amount of Tamoxifen is made, what did they do about this? Well, of course they tried to have the WHO banned!

Open quotesThe very original trial and application for Tamoxifen was turned down by the FDA because of the side effectsClose quotes

If you read the work of Phillip Day and Steve Ransom you will be told that the very original trial and application for Tamoxifen was turned down by the FDA because of the side effects. A while later the same trial was re-presented, and again turned down. Undeterred, and knowing the FDA needed something (anything?) that might help in the fight with breast cancer, the same original trial was re-presented a third time, and gained approval. Is this what Professor Baum regards as the rigorous system to which the likes of Gerson should aspire, one wonders?

Tamoxifen is largely given to women after breast cancer has appeared and to prevent a reoccurrence. However, it is also used as a preventative drug in cases where women are at high risk. As you will see in this issue’s Cancer Watch, new research says that its benefits in these cases are doubtful, whilst its side effects are definitely dangerous. Where were the rigorous clinical trials on Tamoxifen as a preventative agent, for women as yet untouched by cancer? None exists.

In September 2004, the Daily Mail carried a story about Femara (Letrozole), an oestrogen inhibitor, which has just been approved by UK authorities. “Doctors have hailed the drug as a landmark in the treatment of the disease. Until now the “gold standard” has been Tamoxifen. But it can be taken for only five years, after which it becomes less effective and has serious side effects, ” says the article.

The article continues by saying that a third of women with breast cancer have a relapse and more than half of them occur after Tamoxifen has ceased.

Again excuse me for arguing fact here but in 2001 Government figures show that there were 39,000 or so cases of breast cancer and ‘mortality’ was approximately 13,500, which is a bit more than a ‘relapse’.

And whilst I don’t doubt for a minute that these oestrogen-reducing drugs are a major new force in treating breast cancer, I wonder if this indicates just how confused the medical profession as a whole is becoming.

Open quotesWell which one is it? Too little oestrogen, or too much?Close quotes

Hasn’t the same profession been telling women for ten or more years that on reaching menopause it would be a good idea to take more oestrogen because they didn’t have enough. Hasn’t this view spawned enormous income for the pharmaceutical companies in HRT.

Well which one is it? Too little oestrogen, or too much? Either way the pharmaceutical industry has it covered.

(Interestingly the same newspaper, same edition, carried a report from the USA saying that Prozac, and other similar antidepressants like Seroxat, Effexor and Cipramil, all approved in previous trials were now thought to increase the chances of suicide in teenagers! This, of course, raises another point which is how long is enough for a drug trial?)

All I want is honesty. More honesty and less ’spin’ and ‘hype’ It’s not too much to ask, is it? The US solicitor Spitzer has threatened Glaxo with a class action because it extolled the virtues of one of its drugs, without saying too much about the numerous negative side effects found during the trials.

The FDA are so hard pressed monitoring all the trials of all the new drugs they needed more staff. What happened? The nice pharmaceutical companies loaned them some of theirs. The phrase ‘poachers turned gamekeepers’ springs to mind.


In Science Notebook, in The Times in September 2004, Anjana Ahuja wrote:

Honesty is the best medicine if you’re a drugs giant with something to hide

In an interview for T2 last week, Richard Horton, editor of The Lancet, was startlingly candid about how pharmaceutical companies sway research agendas, buy up academics and peddle overpriced, improperly tested drugs. Researchers who take the corporate shilling, he told me, make a “bargain with the Devil”.

Now read this from The New York Review of Books and written by Marcia Angell, the former editor of the New England Journal of Medicine. The pharmaceutical industry is “primarily a marketing machine to sell drugs of dubious benefit… [and] uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the Food and Drugs Administration, academic medical centres, and the medical profession itself”. Angell expands her tirade in a new book, The Truth about Drug Companies: How They Deceive Us and What We Can Do About It.

Their attacks could hardly have been timed better. A fortnight ago 11 medical journals announced that they would refuse to publish the results of clinical trials unless those trials had been registered at their inception. The idea is to prevent companies publishing only flattering results. Since published trials are often pooled in umbrella studies – meta-analyses – the absence of disappointing results, while keeping share prices buoyant, can misrepresent the usefulness and even safety of medicines. Dr Richard Sullivan, from Cancer Research UK, says it is possible that some patients are receiving ineffective drugs because consultants are unaware of negative findings buried in unpublished data. Given that some anti-cancer therapies have unforgiving side-effects, it is a serious matter.

The Pharmaceutical Research and Manufacturers of America, to which giants such as Merck belong, said last week that it would create a database to which companies could voluntarily contribute both good and bad trial results. But the idea met a brutal response. Catherine de Angelis, the editor of the Journal of the American Medical Association, asks: “Why would you put the fox in charge of the hen house?”

Critics have it in for the Big Pharma, and they are certainly not bothering to sugar the pill.


Catherine Woollams

When Catherine was first ill and having radiotherapy she asked her doctors what would they recommend if the treatment failed. They said that they’d been at a US conference and they had a new drug in the US called Gleevec which he wanted to bring in the UK and, they added excitedly, that they could use it for Catherine.

I interjected that Gleevec was made by a Swiss company Novartis. It had been used in trials with 89 glioma patients (in fact, it was called Glivac, previously). It did not work at all. However, in other trials with another cancer (myeloid leukaemia) it had been found to have real merit, it had received FDA approval for that cancer and changed it’s name to Gleevec. Why would you want to give it to my daughter for her glioma?

Worse was to follow. My ex-wife and daughter went to see the doctors when the tumour re-appeared. Who said they planned to use a combination of three drugs, called PCV, and this had ‘a 70 per cent success rate’. This is TOSH. 70 per cent ‘cure’? 70 per cent survive 5 years? What? PCV actually made Catherine so ill she could only take one round. She had no white cells left at all.

Open quotesPCV actually made Catherine so ill she could only take one roundClose quotes

But the medical profession can give you injections to get your white cells back up. Imagine seeing your daughter injecting herself so much she couldn’t walk as a result. And the white cells did not return.

At the Brain Tumour Conference, Angela and Neil Dickson of SDRT told me that they had just been to a conference where scientists said PCV should be banned because it so debilitated the immune system, and it had only ever shown a little success in children under 5.

The doctors next recommended Temozolamide (which anyway only has FDA approval for Grade 3 tumours). This had undergone trials amongst 54 people for just one year, with 5 having their tumour disappear during that time. Is this the sort of standards of excellence required to join Professor Baum’s special club?

This drug didn’t work either, and Catherine’s immune system stayed low and, again, she could not have a second round of the drug.

But then, I truly feel sorry for oncologists. The medical system pushes them towards surgery, radiotherapy and chemotherapy, and for brain tumours, the chemotherapy doesn’t work. You don’t have to believe me. The Lancet in February 2004 says it doesn’t work for brain tumours, just as Professor Pilkington said in icon in May 2003.

Open quotesI truly feel sorry for oncologistsClose quotes

Meanwhile in MD Anderson, they are testing a new type of drug which stops the growth factors of brain cancer cells. It’s called Tarceva. One little problem. Just a little too often it causes a brain haemorrhage!

Chicken and Egg

What are we trying to do? I know that drugs are being developed which will be more targeted and not kill so many good cells. We now understand, much more clearly, the biochemistry of the cancer cell and how it differs from the normal cell and so we can make smart bombs that are far less cytotoxic. I know that others are being developed that, for example like Arimidex, cut the cancer cells’ fuel, or target a unique enzyme or property of the cancer cell. I am all for this.

But.

We seem hell bent on ignoring one, not so little, factor.

Open quotesPeople with weaker immune systems develop more cancersClose quotes

Research in the USA last year came up with the conclusion we all would have expected: People with weaker immune systems develop more cancers. A weak immune system gives you less of the defenders you need to deal with any attacking cancer cell. And remember each of us develops at least 200 or so pre-cancerous cells per day; our immune systems have developed during our evolution to deal effectively with them all.

We have various levels of immune system. To keep it simple I’ll divide it into three parts.

  • friendly bacteria in the gut: These aid digestion, produce biotin (an essential antioxidant) and crucially devour yeasts, microbes and fungi that you ingest daily. Without them your first line of defence is missing.
  • your liver: The largest organ in your body and responsible for cleaning and detoxifying your blood. Without a fully working liver toxins start to pile up around the body causing the whole immune system to ‘clog up’.
  • your white cells: These have a variety of separate but interrelated functions; for example to identify foreign invading cells, to neutralise them and to help remove them from the system.

Let’s take these in turn:

It is quite simply a fact that to take steroids, antibiotics or chemotherapy destroys the friendly bacteria in the gut.

Open quotesTo take steroids, antibiotics or chemotherapy destroys the friendly bacteria in the gutClose quotes

This allows the harmful yeasts, bacteria and microbes to multiply. In the presence of their favourite foods (like sugar, alcohol, refined carbohydrates, dairy and yeasty foods) they will multiply and even enter the blood system. They can colonise in areas of the body and they are anaerobes (don’t need oxygen), just like cancer cells. Some experts go as far as to link their presence to cancer.

The effects of chemotherapy greatly weaken the liver’s detoxification abilities. For example, chemotherapy and radiotherapy kill cells. Some cancer cells, some normal cells. And the dead cells pass to the liver, which has to work hard to break them down and pass them out into the intestines. Cholesterol builds up around some of the dead cells to form stones, sometimes several thousands of them. These in turn block the bile ducts and prevent the elimination of toxins. One US estimate was that virtually every cancer patient had these gallstones. The effects of chemotherapy greatly weaken the liver’s detoxification abilities.

And so the whole immune system ‘backs up’ and it becomes harder to get the toxins out of the body.

But finally, most of these drugs destroy your white cells leaving you with little or none of nature’s defence against foreign cells – like cancer cells.

And that’s the conundrum. At the very moment you need your immune system in tip top working order, most chemotherapy flattens it. Temporarily or even permanently.

Charlotte Gerson

Talk to Charlotte Gerson and she will amplify this further. With brain tumours she claims a success rate of about one third of people coming to her clinic. But if patients have already had chemotherapy, this falls to just 2 or 3 per cent, she says.

Some cancer experts will tell you that patients already have a weakened immune system caused by the cancer. Chicken and egg. But Catherine’s measured blood ’scores’ fell through the floor when she had chemotherapy, and the injections couldn’t return them at all. Indeed it was only a course of Cat’s Claw, Astragalus and organic iron that took her back to somewhere near normal.

Of course some cancers can ‘hide’ from the immune system. But then there are scientists working on ways of ‘kick starting’ the immune system. In icon we already covered one such treatment: Dendritic Cell Therapy.

The $64,000 Question

So, how many doctors and oncologists say to their patients at the moment of diagnosis “Right Mr Jones; the first thing we must do is get your immune system in tip top working order to help it recognise the rogue cells. After all, we want your body in its best fighting shape.”

In Michael Gearin-Tosh’s book (Living Proof: A Medical Mutiny), Dr Wheatley (a doctor of philosophy) quotes Dr Jeffrey Bland, a biochemist who simply states that every cancer therapy should include nutritional consultation as a standard of care. Not to, he says, should be considered, “malpractice by omission”.

Open quotesThe WHO estimate that 50% of all cancers are caused by poor diet; 25% by toxins and 25% by infectionClose quotes

I will tell you now that everyone we talk to, who has just been diagnosed with cancer, is nutritionally toxic (for example, too much salt in their diet) and/or nutritionally deficient (they simply don’t ingest decent levels of antioxidants through diet and/or supplements).

The World Health Organisation is quite clear. They estimate that 50 per cent of all cancers are caused by poor diet; 25 per cent by toxins and 25 per cent by infection.

Do doctors start at this point? Could there be an infection? We have recently completed our own independent blood tests on Catherine and they show that she definitely has a fungal infection in her brain and there is a trace of viral infection. Might not these just possibly be causal?

Of course, the patient may need surgery and it is possible that radiotherapy will help – although US research suggests it only has a 15 per cent 5-year “cure” rate.

And yes, some cancers respond to chemotherapy. But the point is that only a very few can be curedcompletely by chemotherapy, most merely, to some degree, are just managed by chemotherapy. So please will people – supposedly sensible people at that – stop OVERCLAIMING!

Poor Defence

The fact is that if a doctor quickly opts for chemotherapy he is saying that he expects the drug – not your flattened natural defences – to do all the work. And this is simply not credible. Not all the cancer cells may divide during the period of the chemotherapy. Some may even develop their own immunity, and it only needs one to survive.

Open quotesNot all the cancer cells may divide during the period of the chemotherapyClose quotes

Recently I saw some pictures taken using laser light and Russian algae. The chlorophyll in the algae binds to the cancer and pre-cancer cells. The patient had a breast tumour. Before chemotherapy she had three “hot spots” in her breast and a few elsewhere in her body. After chemotherapy the main “hot spots” were smaller but there were a dozen or so around her body.

And there is the rub. Cancer is systemic. The symptoms exist throughout your whole body, they may only manifest themselves in a tumour in one location. This is why it is so hard for radiotherapy or surgery to have long-term effect.

With Catherine recently we discussed what she was doing now versus what she did in year one when cancer was under control. In fact she is more diet conscious now. She doesn’t smoke, take the pill or drink alcohol.

The difference between now and then? A much, much poorer immune system, destroyed by several different chemotherapy drugs the Lancet says don’t work anyway.

Are we angry? No, sad. And completely mystified. Doctors have taken an oath to try to heal people. And to do nothing to harm them. But we feel that doctors don’t even consider the basics.

Open quotesWe feel that doctors don’t even consider the basicsClose quotes

For example:

  • your diet
  • your immune system
  • your chances of yeast or other infection
  • your body energy

Worse, some doctors even laugh, snigger, disparage and discourage patients who dare to suggest taking independent action in these areas.

Actually they’ve probably never even studied them, so it’s not their fault. It’s the fault of the system that trains them and the system that uses all our top doctors, scientists and professors to endlessly test drugs.

Professor Julian Peto of Oxford University and Cancer Research UK was quite clear about this in his speech at the National Conference of Self Help and Support Groups 2003. He stated that there was too much drug research and it took our top doctors and scientists away from investigating possible causes of cancers and bright alternative ideas for their treatment. Certainly if I want to know about cancer causes or complementary therapies the answers rarely lie in the UK or the USA. Most usually the work is taking place in Sweden or Singapore or Australia, Russia or Japan. And what happens when Cancer Research report these findings? Well their PR releases tend to say that the conclusions are “very interesting but more research will have to be done before any action can be taken”. And presumably this means the type of research that gains entry to Professor Baum’s club.

And then they never do it; in the UK we simply do not find the funding for non-drug research.

Open quotesIn the UK we simply do not find the funding for non-drug researchClose quotes

Ask Professor Pilkington whose team has found merit in six natural substances with brain tumours. The project has been scrapped; cancelled for the third time through lack of funding.

We must conduct research on a wide spectrum of possible cancer treatments. Yes, even the Gerson Therapy. Proper research that has one group of people on drugs and an identical group on diet therapy. You see I want to see vigorous research on complementary and alternative therapies too. More research, more honesty, less ’spin’ and less ‘hype’, less uninformed criticism. But the harsh reality is that funding is simply not there. In New York, as we covered in icon in September, Doctor Gonzalez is about to embarrass the FDA. In his diet therapy trial, all but one of his patients has lived the full five years, and considerably longer than those who took the chemotherapy! This is funded by a special US Government body specifically set up to do this sort of research.

You see I actually agree with Professor Baum when he says these other treatments need to be researched or else they will remain on the periphery. But that is not to say that they do not have credibility at the moment. Ask the patients who use them!

Physician Heal Thyself

Open quotesAs I said before, I don’t blame doctorsClose quotes

As I said before, I don’t blame doctors. They work within a system and to recommend vitamin supplements for example over a “tried and trusted” drug might see them struck off.

But this is not to say they couldn’t suggest using vitamin supplements or diet as well. If I ran a cancer clinic I would simply want to do my level best to cure that poor patient sitting in front of me. And I would read and read, study and study and I would want to try different approaches if I didn’t feel the official ones were successful enough.

And let’s face it, with five-year survival rates of 9 per cent on pancreatic cancer, 15 per cent on brain tumours, and even 53 per cent on prostate cancer, I don’t think anyone in UK medicine is in any position to factually disprove me when I say that in my opinion chemotherapy has helped kill my

Tags: , , ,

How scientific are orthodox cancer treatments?

Extracted from Nexus Magazine, Volume 11, Number 4 (June-July 2004)
PO Box 30, Mapleton Qld 4560 Australia.
Updated from: http://www.health-science-spirit.com/cancerscience.html

How scientific are orthodox cancer treatments?

by Walter Last © 2004
Website: http://www.health-science-spirit.com

Treatment often causes more misery than the disease itself and in most cases is unsuccessful (THE CANCER CONSPIRACY by John J. Moelaert)

Research studies and unbiased statistical analysis show that there is no scientific basis for orthodox cancer treatments like radical surgery, chemotherapy and radiation therapy and that these treatments often do more harm than good.

The medical profession takes much pride in the rigorous scientific research that underpins its approach to cancer treatment. Someone newly diagnosed with cancer faces enormous pressure from our health care system to start immediately on a scientific medical treatment program that involves surgery, chemotherapy and radiation in various combinations. Being fearful and in shock, most individuals in this situation are no match for the overwhelming power of medical authority.

How would you react in this situation? You may be leaning towards natural therapies for simple health problems but for something as serious as cancer you may feel safer with the tested and proven methods of orthodox medical care. Nevertheless, if you have the chance, read the following before you make your final decision. You may then have a better appreciation of natural cancer treatment.

In this article I have assembled some little known facts about the science behind orthodox cancer treatment. In cancer research, success (expressed as a five-year survival rate) is established by comparing other forms and combinations of treatment with the results from surgery alone. However, the success rate of surgery has rarely been compared with the survival rates of untreated patients, and never with patients who adopted natural therapies. Therefore, orthodox cancer treatment is inherently unscientific. The overall supposed cure rate is not higher than can be accounted for by spontaneous remissions and the placebo effect.

In support of my position, I offer the following key statements and conclusions from medical and scientific publications.

“Studies appear to show that early intervention is helpful, because pre-cancerous lesions are included in early removals that frequently would notbecome cancerous if left untouched.” In other words, early intervention appears helpful because lesions are removed that are not cancerous but they are counted as being cancer, and that improves survival statistics. “Also, it does not matter how much or how little of a breast is removed; the outcome is always the same “1. This statement indicates that surgery does not improve survival chances; otherwise there would be a difference between radical surgery and lumpectomy.

Researchers have said it is complacent to continue subjecting at least 70% of women with breast cancer to a futile mutilating procedure 2. Furthermore, there is no evidence that early mastectomy affects survival; if patients knew this, they would most likely refuse surgery. 3

In 1993, the editor of The Lancet pointed out that, despite various modifications of breast cancer treatment, death rates remained unchanged. He acknowledged that despite the almost weekly releases of miracle breakthroughs, the medical profession with its extraordinary capacity for self-delusion (his words, not mine) in all truth has lost its way. At the same time, he rejected the view of those who believe that salvation will come from increasing chemotherapy after surgery to just below the rate where it kills the patient. He asked, “would it not be more scientific to ask why our approach has failed?” Not too soon to ask this question after a century of mutilating women, I would say. The title of this editorial, appropriately, is “Breast cancer: have we lost our way?“ 4

Basically, all types and combinations of conventional breast cancer treatment appear to result in the same low long-term survival rates. The only conclusion that can be drawn from this is that conventional treatment does not improve long-term survival rates. Even worse, Michael Baum, MD, a leading British breast cancer surgeon, found that breast cancer surgery tends to increase the risk of relapse or death within three years. He also linked surgery to accelerating the spread of cancer by stimulating the formation of metastases in other parts of the body. 5

An earlier German comparison found that untreated post-menopausal women with breast cancer live longer than treated women, and the recommendation was not to treat postmenopausal women for breast cancer. 6

This conclusion confirms a finding by Ernst Krokowski, a German professor of radiology. He demonstrated conclusively that metastasis is commonly triggered by medical intervention, including sometimes even by a biopsy or surgery unrelated to the cancer. 7 Disturbance of a tumour causes a greatly increased number of cancer cells to enter the bloodstream, while most medical intervention (especially chemotherapy) suppresses the immune system. This combination is a recipe for disaster. It is the metastases that kill, while primary tumours in general, and those in the breast in particular, can be relatively harmless. These findings have been confirmed by recent research which shows that surgery, even if unrelated to the cancer, can trigger an explosive spread of metastases and lead to an untimely end. 8

This follows earlier reports that radical surgery for prostate cancer also tends to spread the disease. Actually, prostate cancer was investigated in the first randomised clinical trials for any type of cancer. After 23 years, there was no difference in the survival rates of those who had surgery and the controls who did not have surgery, but those with surgery suffered more morbidity such as impotence or incontinence. 9

The late H. B. Jones, Professor of Medical Physics, was a leading US cancer statistician. He said in a speech before the American Cancer Society in 1969 that no study has proved that early intervention improves the chances of survival. On the contrary, his studies proved conclusively that untreated cancer victims live up to four times longer and with better quality of life than treated ones. Needless to say, he was not invited again. 10

Massaging Statistics
A recent epidemiological study confirmed the questionable value of conventional therapy by concluding that “medical interventions for cancer have had a negligible or no effect on survival”. 11 Even the conservative New England Journal of Medicine had an article with the headline, “Cancer Undefeated“. 12

Common ways to make medical statistics look more favorable are as follows. Patients who die during prolonged treatment with chemotherapy or radiotherapy are not counted in the statistics, because they did not receive the full treatment. In the control group everyone who dies is counted. Further, success is judged by the percentage of temporary tumor shrinking, regardless of survival times; if survival is measured, then only in terms of dying from the treated disease. It is not normally shown how many of the patients die due to the treatment itself. The current trend is to pick up pre-cancerous conditions very early and treat them as cancer. While this statistically increases the number of people with cancer, it also artificially prolongs survival times and lowers death rates, thereby making medical treatments appear to be more successful. However, there may also be a genuine component of improved survival, as increasing numbers of cancer patients opt for additional natural therapies.

An investigation of the records of 1.2 million cancer patients revealed that the death rate attributed to non-cancer death shortly after treatment was 200% higher than would normally be expected. Two years after diagnosis and treatment, this excess death rate had fallen to 50%. The most common cause for the excess death rate was listed as heart and respiratory failure. This means that, instead of dying several years later from cancer, these patients died from the effects of the treatment and helped greatly improve the cancer statistics because they did not strictly die of cancer. 13 This misleading reporting of cancer deaths has led to demands for more honest statistics.” 14

After an analysis of several large mammogram-screening studies found that mammography screening leads to more aggressive treatment with no survival benefits 15, even the editor of the Lancet had to admit that there is no reliable evidence from large randomized trials to support mammography screening programs 15. The significance of this statement goes far beyond the use of mammograms. It is openly acknowledged by the proponents of conventional medicine that they have no effective way of helping patients with advanced cancer. Until now the catch-cry always was ‘detect it early then it can be cured’. These mammogram evaluation studies demonstrate that it does not matter when cancer is detected, the conventional methods, and with this the whole multi-billion dollar cancer industry, are useless (my conclusion).

A 13-year Canadian study involving 40,000 women compared physical breast examinations with examinations plus mammograms. The mammogram-plus-examination group had many more lumpectomies and surgeries, with a death rate of 107 compared with 105 deaths in the physical examination group.16

Ductal carcinoma in situ (DCIS) is a common, non-invasive form of breast tumour. Most cases of DCIS are detected through the use of mammography. In younger women, 92% of all cancers detected by mammography are of this type. Nevertheless, on average, 44%, and in some areas 60%, of these are treated by mastectomy. As most of these tumours are harmless, this needless treatment makes survival statistics appear to be better than they actually are. 17

While conventional diagnosis is invasive and may help to spread the cancer, a kind of electrodermal screening, called the Biofield test, developed by a team from eight European hospitals and universities, was reported in the Lancet as being 99.1% accurate in diagnosing malignancy in breast tumours. 18

A large meta-analysis of radiotherapy results for lung cancer showed that after two years there were 21% more deaths in the group that had radiotherapy in addition to surgery as compared to those who had surgery alone. The Lancet article 19 stated that the rationale is to kill any cancer cells remaining after surgery, but it is a shame that the facts do not agree with this theory.

Chemotherapy: Medical Russian Roulette
Chemotherapy for children with leukaemia and Hodgkin’s disease is the proud showpiece of the arguably only apparent success of orthodox cancer therapy. Now a long-term follow-up study shows that such children develop 18 times more secondary malignant tumours later in life. Even worse, girls face a 75 times (7,500%) higher risk of breast cancer by the time they are forty. 20 A main problem appears to be the development of deep or systemic Candida albicans infections shortly after commencement of chemotherapy. 21 If these infections are not appropriately treated, then relapses or future health problems are likely to occur.

“Many oncologists take it for granted that response to therapy prolongs survival, an opinion which is based on a fallacy and which is not supported by clinical studies.”

Chemotherapy showed a clear dose dependency whereby the incidence of triggered leukemia doubled between low dose and moderate dose groups and then quadrupled between the moderate dose and the high dose groups. A study of ovarian cancer found that the risk of developing leukaemiaafter treatment with chemotherapy increased 21 fold or 2100%. Also, other tumours commonly develop after treating malignancies with chemotherapy.22 In a trial for multiple myeloma, no advantage was found by using chemotherapy as compared to no treatment. 23

The respected German biostatistician Ulrich Abel presented a comprehensive analysis of over 3,000 clinical trials on the value of chemotherapy for advanced carcinoma (for instance, breast cancer). Oncologists tend to use chemotherapy because this may induce a temporary shrinking of the tumour, called a response; however, it also tends to produce unpleasant side effects. Abel concluded that there is no direct evidence that chemotherapy prolongs survival in these cases. Abel stated: “Many oncologists take it for granted that response to therapy prolongs survival, an opinion which is based on a fallacy and which is not supported by clinical studies.” 24 Ralph W. Moss, PhD, in Questioning Chemotherapy, provides a detailed analysis of this subject. The overall conclusion of the book is that there is no evidence in terms of the majority of cancers that chemotherapy extends life. 25

However, even if chemotherapy could extend life for a few months, what about the quality of this life? Tom Nesi, a former Director of Public Affairs at the pharmaceutical giant Bristol-Myers Squibb, wrote in the New York Times about the successful treatment of his wife, which statistically extended her life for three months. 26 Two weeks after the treatment, she scribbled on a notepad: “depressed — no more — please”. I am not surprised about reports that most oncologists would not have their own family members use these treatments.

Only recently have oncologists started to acknowledge what patients called “chemo-brain”, a distressing loss of memory and other cognitive functions. Psychiatrists have now found that cancer and its conventional treatment cause serious depression in 15 to 25 percent of patients. “The depression itself can often be worse than the disease” they say 27

The Full Treatment
Virginia Livingston (later Livingston-Wheeler), a remarkable cancer researcher and therapist, in her book, Cancer: A New Breakthrough 28, gives an account of one of the many patients she saw who had come to her only after receiving the full medical treatment for breast cancer:

“After discovering a small breast lump, she had radical mastectomy. None of the lymph nodes removed from the armpit were involved; all of the cancer had been successfully removed. To make extra sure that there was no regrowth in the scars, she received radiation treatment, and also her ovaries were taken out.”

“To her dismay, a year later several small nodules appeared in the old breast scar. Again she received radiation. More lumps appeared on the neck that called for still more radiation. In addition, she received male hormone therapy, resulting in acne and coarse facial hair. Still the nodules came back. Now she received chemotherapy with the usual side effects.”

“Before her hair could regrow, pain in her bones was diagnosed as bone cancer. More chemotherapy and hormone therapy was expected to help. However, several months later the bone lesions became worse and removal of her adrenal glands was recommended and performed. Hopefully, that would prolong her suffering for another year. After that the removal of her pituitary gland might give her a further three to six months to live.”

“By now her faith in her medical advisers was sufficiently shaken that she came to Dr Livingston for help. She asked to be examined without her husband being present, as she wanted to spare nun the agony of seeing her naked body, distorted, mutilated and shrunken with an immensely swollen abdomen and thin legs. Finally she whispered: ‘Doctor, shall I kill myself?”

A Conspiracy of Silence
Why are they doing this? With “they”, I am referring to what is commonly called “the Cancer Establishment”. I believe the answer was given by the eminent medical commentator and former editor of New Scientist, Dr Donald Gould, in a timeless article called “Cancer: A Conspiracy of Silence“. The subtitle summarises his position: “The commonest cancers are as resistant to treatment today as they were 40 or 50 years ago. Nothing is to be gained by pretending that the battle against cancer is slowly but surely being won.“ 29

This truth has been deliberately concealed from the general public. According to Gould, the reason for this conspiracy of silence is money. The public must continue to see the Cancer Establishment as a winner to continue providing money. One of the quoted scientists said that with tens of thousands of radiologists and millions of dollars in equipment one just gives radiation treatment even if study after study shows that it does more harm than good.

Gould also is of the opinion that patients who could be comfortable without medical treatment until their inevitable death, with medical treatment are made miserable in a pointless attempt to postpone death for a few unhappy weeks. But of course, that is how most of the money is being made. Gould feels that they poison their patients with drugs and rays and mutilate them with unnecessary surgery in a desperate attempt to treat the untreatable. Not much has changed since Gould wrote this article in 1976. In a recent Moss Report (April 2004) we can read that long-term survival from common cancers such as prostate, breast, colorectal and lung “has barely budged since the 1970s” 30. In summary, this means that there was no significant improvement in cancer survival rates in the last 70 to 80 years.

The Scientific Basis for Drug Approvals

It is also interesting to know the scientific basis for the approval of cancer drugs. Most of them come initially from the U.S.A. Commonly a company had to submit 2 favorable large, randomized trials to obtain FDA approval. ‘Favorable’ means that there must be a certain rate of tumor shrinkage lasting for at least one month. It was not necessary to show that the treatment prolonged survival, and it was not necessary to submit the results of any unfavorable trials for the same drug. Now these ‘strict scientific’ guidelines have been relaxed, and drug companies can get FDA approval on the basis of small preliminary trials, even if a large randomized trial may be unfavorable 31. In a remarkable statement about drug approvals an FDA spokesperson pointed out that any delay in approval did not mean unnecessary deaths because “all these treatments for advanced cancer don’t cure people” 32. However, and this is the important part, an individual cancer drug that does not cure people can earn billions of dollars for its drug company.

Perhaps the situation is even worse than ineffective treatments. A group of respected researchers reviewed all of the published statistical evidence of the outcome of medical treatments. It shows that the medical system is now the leading cause of death and injury in the US. Deaths attributable to heart disease in 2001 were 699,697, for cancer the figure was 553,251, while for medical interventions it was 783,936 per year! Appropriately, the title of this study is ‘Death by Medicine” 33.

You may wonder why health authorities turn a blind eye to these massive drug fatalities, while concentrating their energies instead on suppressing food supplements and natural remedies. A symptom of this official attitude is the recent saga of PAN Pharmaceuticals when in 2003, the Australian government forced the largest Australian manufacturer of natural remedies into bankruptcy, allegedly because there was a possibility that some of these products might cause someone to get sick or even die. I see a main reason for this distorted official attitude in the fact that health departments and regulatory authorities are dominated by medical doctors who have been trained, partly with money from drug companies, to believe that drugs are beneficial and natural remedies potentially harmful. Despite a majority of western populations preferring natural remedies, basically all political parties promote dependency on pharmaceutical drugs. Therefore, as a first step to change this oppressive political climate we urgently need a political party that dares to promote natural health care rather than drug dependency.

We can find a clue for the cause of these appalling “Death by Medicine” statistics in an editorial by Richard Smith in the British Medical Journal. “Yet only 15% of medical interventions are supported by solid scientific evidence”, and “This is because only 1% of the articles in medical journals are scientifically sound, and partly because many treatments have never been assessed at all” 34.

A good demonstration of the unscientific nature of medical research is the recent fiasco with hormone replacement therapy (HRT). Several decades ago it was shown in “rigorous scientific” research to be safe and effective; otherwise it would not have been approved. It was strongly promoted to protect against heart disease and cancer. Now every new trial shows HRT to be dangerous and increasing the risk of developing heart disease and cancer. What went wrong, why has this not been picked up earlier? Quite simply, the original research was conducted with the aim of generating profits, while recent researchers are not sharing in any of these profits. Therefore, I mistrust any research that is conducted with profit in mind. Unfortunately, this presently applies to most medical research.

The Way Forward

It is now 32 years since President Nixon declared the War on Cancer. Since then $US 2 Trillion has been spent on conventional cancer treatment and research, with the result that more individuals are dying of cancer than ever before 35. A similar assessment is given by Clifton Leaf, Executive Editor of the mainstream Fortune magazine. He asks: “Why have we made so little progress in the war on cancer?” and continues to point out that the propaganda about improvement in survival from cancer is largely a myth. Most of the improvement in longevity of cancer patients is due to life style changes and early detection. Early detection prolongs the statistical survival time without the patients living any longer. Even adjusted for age, the percentage of Americans dying from cancer is about the same as it was in 1950. More Americans will die of cancer in the next 14 months than have died from every war that the US has fought combined 36.

While there have been studies to evaluate the effects of various nutrients on different cancers, nothing of these 2 Trillion cancer dollars has been available for natural therapists to trial holistic cancer therapies. Even worse for natural therapists, they had to face a century of persecution. A large number of them was dragged before courts and ended up in jail. Would it not be more scientific to impartially evaluate the methods of natural cancer therapists rather than put them in jail?

In the U.S. basically all alternative cancer clinics had to relocate to Mexico. For a list of such clinics worldwide see http://www.cancure.org. A holistic cancer approach includes superior nutrition, herbs, electro-medicine and vibrational or energy medicine, emotional healing and mind therapy.

The only reported study that comes close to investigating a holistic approach involves the Gerson therapy in an evaluation of 5-year survival rates of 153 melanoma patients. Here 100% of Gerson therapy patients with Stage I and II Cancers survived, but only 79% with conventional therapy. With Stage III (regional metastases) the figures, respectively, were 70% and 41%; with Stage IVa (distant metastases) 39% with Gerson and 6% with conventional therapy 37

Here a few more gems from recent medical publications:

The most important advance in cancer diagnosis is needle biopsy, which is now the standard procedure. Until recently this has just been done on the ‘scientific’ assumption that it is harmless. Now (in 2004) a team in a prestigious US hospital found that 50% of needle biopsies caused metastatic spread of cancer 38. This means an awful number of patients have died due to this innocent-looking procedure.

“Screening for breast cancer with mammography is unjustified. If the trials are judged to be unbiased, the data show that for every 1000 women screened biennially throughout 12 years, one breast cancer death is avoided whereas the total number of deaths is increased by 6.” 39

A group of leading cancer surgeons (Drs. Baum, Demicheli, Hrushesky and Retsky) have shown that surgery triggers accelerated growth of metastases. They point out that from antiquity until relatively recently, surgery was routinely avoided for women with breast cancer precisely because of fear that surgery might spread the disease 40.

The deputy director of the prestigious Canadian National Breast Screening Study (C.J. Baines) wrote: “An unacknowledged harm [of screening mammography] is that for up to 11 years after the initiation of breast cancer screening in women aged 40-49 years, screened women face a higher death rate from breast cancer than unscreened control women, although that is contrary to what one would expect” and “shouldn’t women aged 40-49 years know that, 3 years after screening starts, their chance of death from breast cancer is more than double that for unscreened control women?41

The latest prostate cancer screening study (2006) confirmed an earlier study in 2002 showing that early detection and treatment does not save lives, only increases discomfort 42.

You may be wondering how there can be this contrast between scientific research and public perception of the benefits of conventional cancer therapy. The answer is that research findings are selectively interpreted (spin-doctored) and promoted (propaganda) by vested interests with easy access to the mass media.

Many natural cancer therapists claim a success rate of more than 90% in arresting and reversing cancer, provided that patients have not been subjected to orthodox treatments before. Most harmful appear to be chemotherapy and radiotherapy. Therefore, if you are confronted with cancer, I suggest that you resist acting out of fear and under pressure. The situation is hardly ever so urgent that you have to act immediately. Instead, do your own research from books, journals and the Internet, and then trust your common sense or intuition.

About the Author:
Walter Last worked as a biochemical research chemist in the medical departments of several German i sities and at Bio-Science Laboratories in Los Angeles, USA. He worked as a nutritionist and natural therapist in New Zealand , Australia, where he is now based.

He has written numerous health-related journal articles as v several books, including Heal Yourself and Healing Foods. His new book, The Natural Way to Heal (Hampton Publishing, 2004), is reviewed in this issue. His article, “The Medicine of Dr Hamer”, about Dr Ryke Geerd Hamer’s discovery shock-conflict mechanism underlying cancer development, was published in NEXUS 10/05.

Walter Last is retired and does not have a clinic. For informal health questions, see his website http://www.health-science-spirit.com for his approach to cancer treatment, click on “Diseases” to find his eight-part article, “Overcoming Cancer”.

References
(1) Skrabanek, P.: False Premises and False Promises of Breast Cancer Screening. The Lancet 2: 316-19, 1985
(2) Baum, M.: The Curability of Breast Cancer. Br Med J, 1: 439-42, 1976.
(3) Cunningham, L.: Mastectomy for so-called lobular carcinoma in-situ. Lancet 1: 306, 1980
(4) Editorial: Breast Cancer: Have we lost our way? Lancet 1: 341, 343-44, 1993
(5) Baum, M.: Does surgery disseminate or accelerate cancer? Lancet, 1996 Jan 27; 347(8996): 260
(6) Gregl, A.: Die Lebenserwartung des unbehandelten Mammakarzinoms.: “The life expectancy of the untreated mamma carcinoma (breast cancer)” Klin Wschr 41, 676, 1963
(7) Krokowski, E.H.: Is the Current Treatment of Cancer Self-Limiting in the Extent of its Success? J Int Acad Preventive Medicine, 6 (1) 23 – 39, 1979
(8) Tagliabue E et al : Role of HER2 in wound-induced breast carcinoma proliferation. The Lancet August 16, 2003;362:527-533
(9) Iversen, P. et al.: Radical Prostatectomy versus Expectant Treatment for Early Carcinoma of the Prostate. Scand J Urol Nephrol 172, 65-72, 1995.
(10) Jones, H.B. Lecture at the American Cancer Society Conference, New Orleans July 3/1969
(11) McKinlay, J.B. et al.: A Review of the Evidence Concerning the Impact of Medical Measures on Recent Mortality and Morbidity in the United States. Int. J. Health Services 19, (23), 181-208, 1989.
(12) Bailar JC III, Gornik H.L.: Cancer undefeated. New England Journal of Medicine, 336:1569-1574 (1997)
(13) Brown, B.W., C. Brauner and M.C. Minnotte: Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 85, 979-987, 1993
(14) Welch, H.G., Black, W.C.: Are Deaths Within 1 Month of Cancer-Directed Surgery Attributed to Cancer? J Natl Cancer Inst 94: 1066-1070, 2002
(15) Olsen, O.; Gotzsche, P.C.: Cochrane review on screening for breast cancer with mammography. Lancet 2001 Oct 20; 358:1340-2 and Editorial 1284-85
(16) Miller, A.B., et al.: Canadian National Breast Cancer Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 92, September 20, 2000, pp. 1490-99
(17) Ernster, Virginia L., et al.: Incidence of and treatment for ductal carcinoma in situ of the breast. Journal of the American Medical Association, Vol. 275, No. 12, March 27, 1996, pp. 913-18
Page, David L. and Jensen, Roy A.: Ductal carcinoma in situ of the breast. Journal of the American Medical Association, Vol. 275, No. 12, March 27, 1996, pp. 948-49
(18) Cuzick, Jack, et al.: Electropotential measurements as a new diagnostic modality for breast cancer. The Lancet, Vol. 352, August 1, 1998, pp. 359- 63
(19) PORT Meta-analysis Trialists Group: Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet 1998 Jul 25; 352(9124): 257-63 and Lancet 1998 Jul 25; 352(9124):250-1
(20) Bhatia, S., Robison, L.L. et al.: Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med. 1996 Mar 21;334(12):745-51.
(21) Klingspor, L., Stintzing, G., Tollemar, J. Deep Candida infection in children with leukaemia. Acta Paediatr 86 (1) 30-6, 1997
(22) Klein-Szanto, A.J.P.: Carcinogenic effects of chemotherapeutic compounds. Progress in Clinical and Biological Research, 374, 167-74, 1992.
(23) Riccardi, A., Mora, O.et al.: Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Br J Cancer. 2000 Apr; 82(7):1254-60.
(24) Abel U.: Chemotherapy of advanced epithelial cancer: a critical review. Biomed Pharmacother. 1992; 46(10), 439-52.
(25) Moss, Ralph W.: Questioning Chemotherapy. Equinox Press, Brooklyn, NY, 1995
(26) Nesi, Tom: False hope in a bottle [op-ed], New York Times, June 5/03
(27) Moss, R.W.: THE MOSS REPORTS Newsletter #128 April 11/04
(28) Livingston, Virginia: Cancer: A new Breakthrough. Cancer Book House, Los Angeles, 1972
(29) Gould, D.: Cancer – a Conspiracy of Silence. New Scientist 2 December 1976
(30) Moss, R.W.: THE MOSS REPORTS Newsletter #127 April 4/04
(31) Moss, R.W.: THE MOSS REPORTS Newsletter #86 (June 7/03)
(32) Moss, R.W.: THE MOSS REPORTS Newsletter #122 February 28/04
(33) Null, G, Dean, C. et al.: Death by Medicine. Nutrition Institute of America, Nov 2003, www.NutritionInstituteOfAmerica.org
(34) Smith, R., editor: The poverty of medical evidence. BMJ 303, 5 Oct 1991
(35) Sharon Begley.: New statistics show increase in cancer rates, cancer rates go up, not down. Wall Street Journal, October 16, 2002, B1
(36) Leaf, Clifford. Why we’re losing the war on cancer. Fortune 2004 :149(6):76-97..
(37) Hildenbrand, G.L. et al.: Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: A retrospective review. Alternative Therapies 1(4): 29-37, Sept 1995
(38) Moss, R.W.: THE MOSS REPORTS Newsletters #169 January/30/05 and #170 02/06/05
(39) Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355(9198):129-134
(40) Baum M, Demicheli R, Hrushesky W, et al. Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005 Mar;41(4):508-15
(41) Baines CJ. Mammography screening: Are women really giving informed consent? JNCI 2003;(95) 20:1508-1511.
(42) Concato, J. et al: The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med. 2006 Jan 9;166(1):38-43.

Cashing in on Cancer!

We as a nation seem to rise to the battle, that is unless it involves our health.  In the case of our health we simply defer to people we deem smarter than ourselves.  We rely on their education and network to provide a solution to our condition.  We are a society driven by immediate gratification our health care reflects this today more than ever.

Health care today is driven by pharmaceutical companies and Insurance, we have invested a huge portion of our wages into our health insurance only to find we are then trapped by a system that is relentless in its ability to move money.  Today even the doctor has become a pawn in the game, they are trapped by the legal system into performing only those procedures in a tightly managed group otherwise they are not paid by insurance and stand to be sued.  We no longer have physicians working in the field of Medical Arts, today we have Medical Science – that is the science of control.

So what is the reality of our condition – that when we do get sick there is a predetermined path that our medical care system will provide under the insurance protection we have worked so hard to keep only to find that it does not work…

Take cancer for instance – we have two major modes of therapy today in 2007, they are chemotherapy and radiation.  This seems on the surface to be logical, we know chemo was developed in the 1940’s by the defense department as a biological weapon.  We are aware that chemo is delivered into our system with the knowledge that cancer cells multiply faster than our normal cells and therefore will be more susceptible to the toxic chemical.  I think this is where things start to get fuzzy for us, we think that chemo will somehow only effect the tumor when in fact the science is just trying to kill the tumor before killing the patient.  Has anyone ever explained that in cancer only about 2/3 of the cancer cells are in the state of fast mitosis at any given time and therefore 1/3 are at rest and will not be over exposed to the toxic effect.  You see what we do know is chemo kills but it is a very effective way of extracting dollars and providing hope that is within the scope of Medical Science.

I am going to leave radiation to wikipedia – http://en.wikipedia.org/wiki/Radiation_therapy they seem to do a great job of explaining the short term and long term effects of having radiation therapy – it seems almost comical that radiation causes cancer.

“In 1971 Richard Nixon announced the War on Cancer, and promised a cure by the 1977 bicentennial. In each of the 25 years since, more Americans have died of cancer than the year before.

The failure of chemotherapy to control cancer has become apparent even to the oncology establishment. Scientific American featured a recent cover story entitled: “The War on Cancer – It’s Being Lost.” In it, eminent epidemiologist John C. Bailar III, MD, PhD, Chairman of the Department of Epidemiology and Biostatistics at McGill University cited the relentless increase in cancer deaths in the face of growing use of toxic chemotherapy. He concluded that scientists must look in new directions if they are ever to make progress against this unremitting killer.

Adding its voice, the prestigious British medical journal The Lancet, decrying the failure of conventional therapy to stop the rise in breast cancer deaths, noted the discrepancy between public perception and reality. “If one were to believe all the media hype, the triumphalism of the (medical) profession in published research, and the almost  weekly miracle breakthroughs trumpeted by the cancer charities, one might be surprised that women are dying at all from this cancer” it observed. Noting that conventional therapies — chemotherapy, radiation and surgery — had been pushed to their limits with dismal results, the editorial called on researchers to “challenge dogma and redirect research efforts along more fruitful lines.”

John Cairns, professor of microbiology at Harvard University, published a devastating 1985 critique in Scientific American. “Aside from certain rare cancers, it is not possible to detect any sudden changes in the death rates for any of the major cancers that could be credited to chemotherapy. Whether any of the common cancers can be cured by chemotherapy has yet to be established.”

In fact, chemotherapy is curative in very few cancers — testicular, Hodgkin’s,  choriocarcinoma, childhood leukemia.  In most common solid tumors — lung, colon, breast, etc. — chemotherapy is NOT curative.

In an article entailed “Chemotherapy: Snake-Oil Remedy?” that appeared in the Los Angeles Times of 1/9/87, Dr.  Martin F. Shapiro explained that while “some oncologist  inform their patients of the lack of evidence that treatments work…others may well be misled by scientific papers that express unwarranted optimism about chemotherapy.  Still others respond to an economic incentive. Physicians can earn much more money running  active chemotherapy practices than they can providing solace and relief.. to dying patients and their families.”

Dr. Shapiro is hardly alone. Alan C. Nixon, PhD, Past President of the American Chemical Society wrote that “As a chemist trained to interpret data, it is incomprehensible to me that physicians can ignore the clear evidence that  chemotherapy does much, much more harm than good.”

In 1986, McGill Cancer Center scientists sent a questionnaire to 118 doctors who treated non-small-cell lung  cancer. More than 3/4 of them recruited patients and carried out trials of toxic drugs for lung cancer. They were  asked to imagine that they themselves had cancer, and were asked which of six current trials they themselves would choose. 64 of the 79 respondents would not consent to be in a trial containing cisplatin, a common chemotherapy drug. Fifty eight found all the trials unacceptable. Their reason? The ineffectiveness of chemotherapy and its unacceptable degree of toxicity.

Famed German bio statistician Ulrich Abel, PhD, also found in a similar 1989 study that “the personal views of many oncologists seem to be in striking contrast to communications intended for the public.”

Colorectal: no evidence exists that survival is improved by chemotherapy.
Gastric: no clear evidence.
Pancreatic: largest study “completely negative.” Longer survival in the control group untreated.
Bladder: no clinical trial done.
Breast: no direct evidence that chemotherapy prolongs survival. Use is “ethically questionable.”
Ovarian: no direct evidence, but probably a small advantage from cis-platinum regimens. But non-randomized comparisons “almost worthless for assessment of therapy.
Cervix and corpus uteri: no improved survival.
Head and neck: no survival benefit, but occasional “positive effect” from shrinkage of tumors.

Breast cancer activist Rose Kushner wrote that by 1981 “indiscriminate, automatic adjuvant chemotherapy was replacing the Halsted radical mastectomy as therapeutic overkill in the United States.” Thomas Nealon MD, Professor of Surgery at NYU School of Medicine, Concluded in 1990 that “The treatment of this tumor now has slipped from too much surgery to too much adjuvant therapy.”